{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":81,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":81,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ed0f6a6f7fe7","filters":{"venue":"PharmacoEconomics - Open"}},"results":[{"id":"W3215778396","doi":"10.1007/s41669-021-00311-5","title":"Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries","year":2021,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Consumers, Health, Agriculture and Food Executive Agency; Directorate-General for Health and Consumers","keywords":"Health technology; Transparency (behavior); Scope (computer science); Negotiation; European union; Transformative learning; Business; Political science; Public economics; Process management; Medicine; Health care; Psychology; Computer science; Economics","authors":[{"name":"Anna-Maria Fontrier","is_ca":false},{"name":"Erica Visintin","is_ca":false},{"name":"Panos Kanavos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6845194897058882,"gpt":0.5941363569088085,"spread":0.09038313279707966,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.01217093,0.0005418815,0.005587723,0.000732269,0.0004469192,0.001240367,0.001076231,0.0003934518,0.0001110599],"category_scores_gemma":[0.001874557,0.0006594304,0.0001619939,0.0002144525,0.0001733452,0.001063145,0.0007510693,0.000455036,0.00005070147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00155203,"about_ca_system_score_gemma":0.001773597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003535036,"about_ca_topic_score_gemma":0.0005599276,"domain_scores_codex":[0.9904242,0.0006208736,0.00679812,0.001535537,0.00004955143,0.0005716825],"domain_scores_gemma":[0.9838657,0.01042479,0.004579561,0.000779203,0.00008264173,0.0002680621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003455152,0.0003140003,0.05163218,0.04829475,0.001571082,0.000003962358,0.001465466,0.00007333434,1.341716e-7,0.6815272,0.03788323,0.1772001],"study_design_scores_gemma":[0.0008289134,0.00006121579,0.001046761,0.01259143,0.00007269248,0.0000158519,0.0006177606,0.001281111,4.782131e-8,0.01397723,0.9688416,0.000665358],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005659742,0.955744,0.002162784,0.02581386,0.0006976982,0.005837331,0.009024967,0.00003220958,0.0001211438],"genre_scores_gemma":[0.0006644922,0.9881464,0.003130478,0.003112858,0.0002052457,0.004106484,0.000390896,0.00007572671,0.0001673854],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9309584,"threshold_uncertainty_score":0.9997965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2952476208","doi":"10.1007/s41669-019-0143-2","title":"The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Retrospective cohort study; Medicine; Environmental health; Cohort; Population; Population health; Database; Family medicine; Business; Computer science","authors":[{"name":"Cody Black","is_ca":true},{"name":"Kednapa Thavorn","is_ca":true},{"name":"Doug Coyle","is_ca":true},{"name":"Lise M. Bjerre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1620565774407131,"gpt":0.4340308402737773,"spread":0.2719742628330641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959584,0.0002148979,0.0008262833,0.00006711441,0.0002121667,0.00007976806,0.0003461344,0.00002057611,0.0001205098],"category_scores_gemma":[0.00006144479,0.0001760552,0.00005531809,0.0001215013,0.00002391377,0.0003449714,0.0001998907,0.0004866215,0.000003640553],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007148725,"about_ca_system_score_gemma":0.008276101,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9925568,"about_ca_topic_score_gemma":0.9823747,"domain_scores_codex":[0.9974133,0.0004387319,0.001007818,0.000466024,0.0002890972,0.0003849737],"domain_scores_gemma":[0.9979204,0.0003367744,0.0009569637,0.0004209529,0.0001006309,0.0002642596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001605274,0.0003399946,0.9958871,0.0001149503,0.0002384654,0.000009784802,0.0003009472,0.0007496702,0.0000152799,0.0003014011,0.0001700625,0.0002670603],"study_design_scores_gemma":[0.00538355,0.0005589245,0.9612184,0.0002513066,0.0001055442,0.000008050783,0.001560723,0.02929077,0.00005131757,0.000004078643,0.001375414,0.0001918971],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879091,0.0001027842,0.00002444397,0.001772076,0.0006834005,0.008577214,0.0001433248,0.00001147888,0.0007762142],"genre_scores_gemma":[0.997488,0.00002060838,0.0003186316,0.001780564,0.00003102075,0.00006546444,0.0001594469,0.00002608242,0.0001102345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03466868,"threshold_uncertainty_score":0.997346,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015688173","doi":"10.1007/s41669-020-00212-z","title":"Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Tianjin University; National Natural Science Foundation of China","keywords":"Anxiety; CLARITY; Relevance (law); Qualitative research; Psychology; China; Mental health; Population; Clinical psychology; Gerontology; Medicine; Psychiatry; Environmental health; Geography; Sociology; Social science; Political science","authors":[{"name":"Fan Yang","is_ca":false},{"name":"Shan Jiang","is_ca":true},{"name":"Xiaoning He","is_ca":false},{"name":"Hongchao Li","is_ca":false},{"name":"Hongyan Wu","is_ca":false},{"name":"Tiantian Zhang","is_ca":false},{"name":"Jing Wu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6214977604419405,"gpt":0.5467421121684448,"spread":0.07475564827349568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01618493,0.000476568,0.001922621,0.0003397324,0.0002474661,0.00084558,0.002105282,0.0001464479,0.004006015],"category_scores_gemma":[0.003135129,0.0006426575,0.0001719814,0.0003395608,0.0001130529,0.003189325,0.0009244204,0.0005931805,0.006789116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001656268,"about_ca_system_score_gemma":0.0004289241,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05400373,"about_ca_topic_score_gemma":0.002384928,"domain_scores_codex":[0.9908954,0.001480705,0.005336966,0.001447498,0.0001403598,0.0006990746],"domain_scores_gemma":[0.9940401,0.002079545,0.002507744,0.0007324869,0.00005293549,0.0005872244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"qualitative","study_design_scores_codex":[0.001342385,0.000829338,0.1601547,0.0002688956,0.0008947532,0.00003411471,0.7500094,0.00128279,0.00004537408,0.02272407,0.06192995,0.0004842056],"study_design_scores_gemma":[0.01803696,0.001172122,0.09972031,0.0006647272,0.0001025281,0.000007864738,0.6859762,0.02378985,0.0001303446,0.1590354,0.008418737,0.002944978],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9221451,0.002153587,0.0004988236,0.06488504,0.0007531383,0.003549798,0.0006807005,0.00006126086,0.005272516],"genre_scores_gemma":[0.9755626,0.0004894224,0.0007026712,0.02210125,0.0004067955,0.0002885592,0.00005777988,0.00008597401,0.0003049013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1363113,"threshold_uncertainty_score":0.9996025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103580978","doi":"10.1007/s41669-020-00241-8","title":"The Actual Operative Costs of Liver Transplantation and Normothermic Machine Perfusion in a Canadian Setting","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"","keywords":"Liver transplantation; Procurement; Medicine; Transplantation; Machine perfusion; Total cost; Perfusion; Marginal cost; Operations management; Surgery; Emergency medicine; Business; Internal medicine; Economics; Accounting","authors":[{"name":"Alexandria N. Webb","is_ca":true},{"name":"Dayne L. Izquierdo","is_ca":true},{"name":"Dean T. Eurich","is_ca":true},{"name":"A. M. James Shapiro","is_ca":true},{"name":"David L. Bigam","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01892164509931704,"gpt":0.3280509178730727,"spread":0.3091292727737557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002024291,0.00008235029,0.0001559939,0.00004300735,0.00008045949,0.00003916648,0.0001235423,0.00002822812,0.0001815048],"category_scores_gemma":[0.000009225694,0.00006412698,0.00002013523,0.00004545175,0.00003082926,0.0001434871,0.00001979386,0.0001189302,0.000006916978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008601032,"about_ca_system_score_gemma":0.000163247,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.07504242,"about_ca_topic_score_gemma":0.1080588,"domain_scores_codex":[0.9994558,0.00003512844,0.0002097657,0.0001366629,0.00003250551,0.0001301246],"domain_scores_gemma":[0.9996496,0.0000793002,0.0000509282,0.00005101384,0.0000172152,0.0001519261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006614652,0.0001713567,0.4689235,0.001469776,0.0003475067,0.0005835251,0.08846069,0.0002184911,0.1008116,0.004463827,0.001949578,0.3259854],"study_design_scores_gemma":[0.0207164,0.0009010105,0.3894863,0.0004483238,0.0006511681,0.0003602941,0.00210799,0.1593992,0.4066514,0.00009474064,0.01825251,0.0009305737],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875887,0.0002306035,0.00005842646,0.009083748,0.0000236903,0.0007868736,0.0001366393,0.00001030675,0.002081036],"genre_scores_gemma":[0.9879128,0.007556327,0.0004038238,0.003999012,0.00002141921,0.00001190678,0.00004518737,0.00001343441,0.00003613532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3250549,"threshold_uncertainty_score":0.9311169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224952615","doi":"10.1007/s41669-022-00330-w","title":"Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis","year":2022,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Disease; Perspective (graphical); Medicine; Intensive care medicine; Medical costs; Health care; Pathology; Computer science; Political science","authors":[{"name":"Zachary K. Baldwin","is_ca":false},{"name":"Boshen Jiao","is_ca":false},{"name":"Anirban Basu","is_ca":false},{"name":"Joshua A. Roth","is_ca":false},{"name":"M. A. Bender","is_ca":false},{"name":"Zizi Elsisi","is_ca":false},{"name":"KATE JOHNSON","is_ca":false},{"name":"Emma M. Cousin","is_ca":false},{"name":"Scott D. Ramsey","is_ca":false},{"name":"Beth Devine","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01844975108290345,"gpt":0.3638666715506593,"spread":0.3454169204677558,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007819185,0.0004438559,0.004552201,0.0002170159,0.00009909386,0.00005642741,0.0003708345,0.0002042297,0.004159336],"category_scores_gemma":[0.0002446802,0.0003236007,0.0003810871,0.000273272,0.0001428338,0.00008599682,0.0007469149,0.0005176182,0.00001280614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002068008,"about_ca_system_score_gemma":0.0008095662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009064053,"about_ca_topic_score_gemma":0.00002460815,"domain_scores_codex":[0.9973855,0.0003206708,0.001041797,0.0007186273,0.0002995651,0.0002338648],"domain_scores_gemma":[0.9975052,0.0004500335,0.0005595973,0.0003990626,0.00003220947,0.001053841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001306067,0.0007351212,0.0008816226,0.9369849,0.01964022,0.0006373186,0.0002699214,3.866301e-7,9.837537e-8,0.00002415444,0.001684019,0.03901163],"study_design_scores_gemma":[0.01144422,0.0003722073,0.0001454874,0.3164686,0.5002857,0.0004067152,0.0008381801,0.003886173,3.336185e-7,0.00003818131,0.164778,0.001336135],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00135518,0.992048,0.000001822125,0.0005620528,0.00005868467,0.00415427,0.0006149309,0.00001085229,0.001194234],"genre_scores_gemma":[0.0004647711,0.9970506,0.0000195793,0.001237128,0.00003520238,0.0004516765,0.0004484998,0.00004770021,0.0002448271],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6205163,"threshold_uncertainty_score":0.9999216,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766253633","doi":"10.1007/s41669-017-0061-0","title":"The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian VIGOUR Centre; Institute of Health Economics; Alberta Hospital Edmonton; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Health care; Ambulatory care; Ambulatory; Emergency medicine; Acute care; Myocardial infarction; Population; Liberian dollar; Total cost; Medical emergency; Inpatient care; Environmental health; Business; Finance; Internal medicine","authors":[{"name":"Dat T. Tran","is_ca":true},{"name":"Arto Öhinmaa","is_ca":true},{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Robert C. Welsh","is_ca":true},{"name":"Padma Kaul","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04275009629830681,"gpt":0.397792840425913,"spread":0.3550427441276062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007354251,0.0001470058,0.0004200538,0.00006495533,0.0004966758,0.0002082357,0.001005063,0.00006535371,0.0001301148],"category_scores_gemma":[0.0001180961,0.0001251583,0.0001088438,0.00005380595,0.0001543945,0.0003365097,0.0006521767,0.0004132142,0.00004289357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000712969,"about_ca_system_score_gemma":0.001982124,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9724072,"about_ca_topic_score_gemma":0.6311108,"domain_scores_codex":[0.9985774,0.00009585947,0.0004614739,0.0002865842,0.0001900554,0.0003886369],"domain_scores_gemma":[0.9983318,0.0001946657,0.0002904738,0.0007905309,0.0001499757,0.0002424878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006163085,0.0001472027,0.1581082,0.0001509601,0.006481543,0.0001435352,0.001317367,0.0008692766,0.003487968,0.004192827,0.6808234,0.1381147],"study_design_scores_gemma":[0.003860963,0.0000812532,0.05472494,0.00003380742,0.000139391,0.00004194779,0.0002066209,0.002937987,0.002206548,0.0001332752,0.9354396,0.0001936091],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3883956,0.0001761562,0.000005853377,0.5503879,0.002439118,0.004521715,0.0003006973,0.0000129713,0.05376005],"genre_scores_gemma":[0.9887329,0.001522301,0.0000401595,0.00646887,0.0004094788,0.000193074,0.00004777516,0.00003072874,0.002554763],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6003373,"threshold_uncertainty_score":0.5103808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2935761670","doi":"10.1007/s41669-019-0132-5","title":"Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Akebia Therapeutics; Otsuka Pharmaceutical","keywords":"Medicine; Observational study; Quality of life (healthcare); Cochrane Library; Randomized controlled trial; Intensive care medicine; Kidney disease; Population; MEDLINE; Dialysis; Pediatrics; Internal medicine; Environmental health","authors":[{"name":"Pablo E. Pérgola","is_ca":false},{"name":"Roberto Pecoits‐Filho","is_ca":false},{"name":"Wolfgang C. Winkelmayer­","is_ca":false},{"name":"Bruce Spinowitz","is_ca":false},{"name":"Samuel Rochette","is_ca":true},{"name":"Philippe Thompson‐Leduc","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Gigi Shafai","is_ca":false},{"name":"Ana Bozas","is_ca":false},{"name":"Myrlene Sanon","is_ca":false},{"name":"Holly B. Krasa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1412128731212003,"gpt":0.4430817841296246,"spread":0.3018689110084243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001386704,0.0006978892,0.008289521,0.0002048476,0.00005715475,0.00004587169,0.0003361188,0.0001436019,0.00006110511],"category_scores_gemma":[0.0000804324,0.0004560807,0.0003788047,0.0001262305,0.00005425175,0.0001214038,0.0001147865,0.0003037469,0.00004155105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002117419,"about_ca_system_score_gemma":0.001269708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004978332,"about_ca_topic_score_gemma":0.00006616203,"domain_scores_codex":[0.9955735,0.0004511404,0.00263016,0.0008204348,0.0001484339,0.0003762967],"domain_scores_gemma":[0.9951009,0.0004440417,0.003519151,0.0006121116,0.00007254643,0.0002512699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006839195,0.0009356232,0.003139051,0.9217989,0.008251034,0.000002284921,0.0001086552,0.000009432485,1.096184e-8,0.00003939772,0.0005435456,0.06448817],"study_design_scores_gemma":[0.02873776,0.00232515,0.001226173,0.9338089,0.02231855,0.000003984291,0.00002341894,0.0000509915,6.500941e-7,0.000004498984,0.01066179,0.0008381288],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005556876,0.9678339,2.842347e-7,0.0004410373,0.0001279105,0.02493932,0.0009305567,0.00001655209,0.0001536051],"genre_scores_gemma":[0.001605026,0.9934144,0.00003917688,0.000399081,0.0000271886,0.001880544,0.002343322,0.0001049761,0.0001862629],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.06365004,"threshold_uncertainty_score":0.9997891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2555011614","doi":"10.1007/s41669-016-0007-y","title":"Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicaid; Reimbursement; Quarter (Canadian coin); Medical prescription; Pharmacy; Medicine; Prescription drug; Population; Family medicine; Environmental health; Pharmacology; Health care; Geography; Economic growth; Economics","authors":[{"name":"Ziyad S. Almalki","is_ca":false},{"name":"Xiaomeng Yue","is_ca":false},{"name":"Ying Xia","is_ca":false},{"name":"Patricia R. Wigle","is_ca":false},{"name":"Jeff J. Guo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1063738117336394,"gpt":0.4256349832234699,"spread":0.3192611714898306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005636213,0.0001548007,0.0002585662,0.0001132177,0.00007176147,0.0001103466,0.0004818054,0.00005567139,0.0003043443],"category_scores_gemma":[0.00005090137,0.0001010211,0.00004614318,0.0001298088,0.000153179,0.0002249978,0.0001942067,0.00009975476,0.00002270696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000053935,"about_ca_system_score_gemma":0.00004535963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008339083,"about_ca_topic_score_gemma":0.0000233244,"domain_scores_codex":[0.9988591,0.00003791297,0.0003363573,0.0003566551,0.00009563721,0.0003143285],"domain_scores_gemma":[0.9993418,0.0001206,0.000126147,0.0002323116,0.00003311211,0.0001460415],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001366904,0.001506818,0.230036,0.000191526,0.0003048884,0.00007507783,0.01265614,0.00001019563,0.01109971,0.008978879,0.05337047,0.6804034],"study_design_scores_gemma":[0.009498189,0.0003455313,0.08310685,0.000128874,0.0001276341,0.00007560079,0.000427882,0.002513565,0.003824102,0.0002789221,0.8993261,0.000346707],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872091,0.0003666049,0.0002210541,0.007574097,0.0002918372,0.00126695,0.00002872662,0.00002518293,0.003016444],"genre_scores_gemma":[0.9952022,0.001385792,0.000569752,0.001604538,0.0002132155,0.00009387265,0.00004624961,0.00002826844,0.000856065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8459557,"threshold_uncertainty_score":0.411952,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2933306415","doi":"10.1007/s41669-019-0131-6","title":"Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Dulaglutide; Semaglutide; Type 2 diabetes; Medicine; Internal medicine; Diabetes mellitus; Endocrinology; Exenatide; Liraglutide","authors":[{"name":"Pierre Johansen","is_ca":false},{"name":"Jonas Håkan‐Bloch","is_ca":false},{"name":"Aiden R. Liu","is_ca":false},{"name":"Peter G. Bech","is_ca":false},{"name":"Sofie Persson","is_ca":false},{"name":"Lawrence A. Leiter","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04761554358127133,"gpt":0.3363003955237773,"spread":0.288684851942506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004997685,0.0002367011,0.0007645194,0.0001264574,0.00001907608,0.00002067119,0.0004161568,0.00003396831,0.0001957974],"category_scores_gemma":[0.00001678179,0.0001842828,0.00008244944,0.0002169626,0.00004133736,0.0001342146,0.0001092862,0.00008901675,0.000037153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002047129,"about_ca_system_score_gemma":0.0009412865,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3802235,"about_ca_topic_score_gemma":0.2535291,"domain_scores_codex":[0.9985499,0.0001690651,0.0004585477,0.0003332014,0.000131452,0.0003578638],"domain_scores_gemma":[0.9986256,0.0006414104,0.0001907397,0.0004257833,0.00003994153,0.00007654055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003993364,0.001829087,0.9604909,0.0004431704,0.001006999,0.00004833877,0.0006910863,0.003424759,0.002665512,0.000408862,0.0009734979,0.02402445],"study_design_scores_gemma":[0.06983942,0.005240975,0.7620916,0.0006952861,0.0009711111,0.000001756172,0.002063901,0.009664017,0.09033593,0.0001503132,0.05822296,0.0007227757],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848267,0.0004001824,1.790657e-7,0.0004847929,0.0005357175,0.003586019,0.00005169331,0.000005126071,0.01010958],"genre_scores_gemma":[0.998567,0.0003981474,0.00006026597,0.0002423902,0.00002747077,0.000210202,0.00008385842,0.00002513845,0.0003855221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1983993,"threshold_uncertainty_score":0.7600921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2801866300","doi":"10.1007/s41669-018-0083-2","title":"Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; International Collaboration On Repair Discoveries; Simon Fraser University; Vancouver Coastal Health","funders":"National Institute for Health and Care Research; Ontario Stroke Network; SFU Community Trust Endowment Fund; Health Technology Assessment Programme; Simon Fraser University; Tavistock Trust for Aphasia; EuroQol Research Foundation; Research for Patient Benefit Programme; Ontario Ministry of Health and Long-Term Care","keywords":"Valuation (finance); Preference; Process (computing); Quality of life (healthcare); Psychology; Conceptual framework; Quality (philosophy); Applied psychology; Computer science; Medicine; Nursing; Business; Sociology; Social science","authors":[{"name":"David G. T. Whitehurst","is_ca":true},{"name":"Nicholas Latimer","is_ca":false},{"name":"Aura Kagan","is_ca":false},{"name":"Rebecca Palmer","is_ca":false},{"name":"Nina Simmons‐Mackie","is_ca":false},{"name":"J. Charles Victor","is_ca":true},{"name":"Jeffrey S. Hoch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6861002413643779,"gpt":0.5569994370974879,"spread":0.12910080426689,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03840426,0.0002239472,0.002175181,0.0003971343,0.0002444065,0.00004239999,0.0007167494,0.00008867691,0.000211386],"category_scores_gemma":[0.003715949,0.0002468076,0.00008772109,0.0002340565,0.0003227601,0.0006918031,0.0004122431,0.0001423034,0.000008785657],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002439298,"about_ca_system_score_gemma":0.007165517,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.831916,"about_ca_topic_score_gemma":0.3002147,"domain_scores_codex":[0.9891554,0.000934597,0.00888639,0.0005569324,0.00009601797,0.0003706676],"domain_scores_gemma":[0.9873623,0.002858166,0.008865564,0.0004957195,0.0002979318,0.0001203187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004695238,0.0002913108,0.5233045,0.00405032,0.004028706,0.000001078341,0.01591404,0.005686838,0.00003594145,0.4077182,0.03296711,0.001306688],"study_design_scores_gemma":[0.1686106,0.001454909,0.3176939,0.002453128,0.000528384,0.0000515977,0.04289826,0.2137694,0.002346907,0.168261,0.07797147,0.003960375],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9783393,0.001115156,0.00008339131,0.01398366,0.002163451,0.003327107,0.0005637795,0.000006062207,0.0004180658],"genre_scores_gemma":[0.9955556,0.0003433544,0.001509228,0.001947122,0.0001221734,0.0003122792,0.0001421711,0.00002869608,0.00003932555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5317012,"threshold_uncertainty_score":0.9999984,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2942619274","doi":"10.1007/s41669-019-0142-3","title":"A Systematic Review of the Health Economics of Pompe Disease","year":2019,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Audentes Therapeutics","keywords":"Medicine; Enzyme replacement therapy; Life expectancy; Disease; Quality of life (healthcare); Quality-adjusted life year; Health economics; MEDLINE; Health care; Economic evaluation; Systematic review; Indirect costs; Pediatrics; Cost effectiveness; Family medicine; Physical therapy; Environmental health; Public health; Internal medicine; Nursing; Pathology","authors":[{"name":"Benedikt Schoser","is_ca":false},{"name":"Andreas Hahn","is_ca":false},{"name":"Emma S. James","is_ca":false},{"name":"Digant Gupta","is_ca":false},{"name":"Matthew Gitlin","is_ca":false},{"name":"Suyash Prasad","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1245908268084915,"gpt":0.473416101944346,"spread":0.3488252751358544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001857661,0.0004462653,0.006812083,0.0001575713,0.00005345846,0.0000399411,0.002348379,0.00009493908,0.0005291873],"category_scores_gemma":[0.0003416276,0.0002972288,0.001391803,0.0002375884,0.0001115221,0.0001483235,0.001293461,0.0004614116,0.0002371868],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007197185,"about_ca_system_score_gemma":0.006014208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001697846,"about_ca_topic_score_gemma":0.000005726499,"domain_scores_codex":[0.9956675,0.0006115703,0.002632638,0.000535064,0.0001822611,0.000370999],"domain_scores_gemma":[0.9945017,0.0003113727,0.002961535,0.001728648,0.0001327504,0.0003640107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003623637,0.0001398572,0.000007758559,0.9741955,0.0009182022,0.000001650714,0.00001897275,9.453807e-7,5.493927e-8,0.0002496639,0.003163831,0.02126732],"study_design_scores_gemma":[0.0005847006,0.00005518653,0.000001654288,0.6497909,0.003525597,0.0000221666,0.000007909193,0.00004642842,0.00000100124,0.00001690461,0.3457545,0.0001929719],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001119058,0.9759646,9.629126e-7,0.0009964597,0.0003007739,0.02010996,0.0006477578,0.000007464535,0.001960814],"genre_scores_gemma":[0.000009493649,0.9951323,0.00003543987,0.00256429,0.00005598391,0.0005423839,0.0001656006,0.000107383,0.001387132],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3425907,"threshold_uncertainty_score":0.999948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3210263997","doi":"10.1007/s41669-021-00309-z","title":"Community Distribution of Naloxone: A Systematic Review of Economic Evaluations","year":2021,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact","funders":"","keywords":"(+)-Naloxone; EconLit; Medicine; Quality (philosophy); Economic evaluation; MEDLINE; Actuarial science; Business; Opioid; Political science","authors":[{"name":"Nelda Cherrier","is_ca":true},{"name":"Joanne Kearon","is_ca":true},{"name":"Robin Tetreault","is_ca":true},{"name":"Sophiya Garasia","is_ca":true},{"name":"G. Emmanuel Guindon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1185071507510415,"gpt":0.4933644225600569,"spread":0.3748572718090154,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002114007,0.0004380684,0.006500265,0.0001093501,0.00008008182,0.00003478829,0.0008656948,0.0001306543,0.0008178634],"category_scores_gemma":[0.0002731323,0.0003914111,0.001011672,0.0001590743,0.00006656259,0.0001455399,0.0005810989,0.0004449059,0.0001800573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001097354,"about_ca_system_score_gemma":0.002633573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003745341,"about_ca_topic_score_gemma":0.00001245555,"domain_scores_codex":[0.9955302,0.00124106,0.002577213,0.0003298007,0.000124563,0.0001971209],"domain_scores_gemma":[0.9955794,0.0004579617,0.002239247,0.001382747,0.0002052525,0.0001353747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000006718765,0.00047228,0.000003109256,0.9808691,0.002360122,0.000001930101,0.00005708323,0.00000109848,3.051862e-7,0.0003447039,0.002124613,0.01375898],"study_design_scores_gemma":[0.0009507005,0.00008717719,0.000003016051,0.844521,0.02918131,0.00006240246,0.00006980769,0.0000398309,0.00002183823,0.00002407928,0.1247672,0.0002715538],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002551271,0.9859895,0.00001545159,0.000137364,0.000205461,0.009912416,0.002334302,0.00001230073,0.001367651],"genre_scores_gemma":[0.00003156428,0.9877105,0.0001756309,0.0001792403,0.00003175367,0.001441205,0.01014293,0.000061609,0.0002255445],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.136348,"threshold_uncertainty_score":0.9998538,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2744741417","doi":"10.1007/s41669-017-0049-9","title":"Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Statistics; Logistic regression; Ordinary least squares; Regression diagnostic; Regression analysis; Segmented regression; Censored regression model; Regression; Mathematics; Econometrics; Local regression; Cross-sectional regression; Linear regression; Polynomial regression","authors":[{"name":"Ralph Crott","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8025354787775343,"gpt":0.6055012823377216,"spread":0.1970341964398127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02039883,0.0002652057,0.001882443,0.0002308772,0.0005504916,0.0002808962,0.003410844,0.000127683,0.0006866608],"category_scores_gemma":[0.003082034,0.0002603643,0.0002296957,0.0001080583,0.0001610481,0.0009139081,0.00137204,0.0002286344,0.0003288279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003731526,"about_ca_system_score_gemma":0.0002658599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003757488,"about_ca_topic_score_gemma":0.0002621192,"domain_scores_codex":[0.9937305,0.0006020821,0.004456238,0.0006876214,0.00007495489,0.0004486283],"domain_scores_gemma":[0.9896879,0.000989362,0.007296662,0.001683617,0.00009340198,0.0002490516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003142349,0.0007691454,0.7599544,0.001637826,0.000966667,5.351607e-7,0.02135892,0.003187155,0.002511039,0.0553338,0.130384,0.02358232],"study_design_scores_gemma":[0.00565776,0.0002839421,0.2632221,0.001579942,0.0001084582,0.000004430518,0.004153287,0.04755493,0.04222999,0.03288351,0.6004518,0.001869828],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8572932,0.00143175,0.004150571,0.02696128,0.003207429,0.003673757,0.0008267472,0.00003283369,0.1024224],"genre_scores_gemma":[0.9703265,0.0001329015,0.02452187,0.003468124,0.0002026121,0.000185867,0.00001052511,0.00004511041,0.00110644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4967323,"threshold_uncertainty_score":0.9999849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4295905156","doi":"10.1007/s41669-022-00363-1","title":"Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Novartis (Canada); EVERSANA (Canada); Memorial University of Newfoundland; University of British Columbia; Queen's University","funders":"Novartis Pharmaceuticals Canada","keywords":"Relapsing remitting; Ofatumumab; Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Internal medicine; Psychiatry","authors":[{"name":"Moogeh Baharnoori","is_ca":true},{"name":"Virender Bhan","is_ca":true},{"name":"Fraser Clift","is_ca":true},{"name":"Kimberly Thomas","is_ca":true},{"name":"Soukaïna Mouallif","is_ca":true},{"name":"Nicholas Adlard","is_ca":false},{"name":"Philip Cooney","is_ca":false},{"name":"François Blanchette","is_ca":true},{"name":"Barkha P. Patel","is_ca":true},{"name":"Daniel Grima","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2283981779288735,"gpt":0.4132400132269685,"spread":0.184841835298095,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010126,0.000150914,0.0008433748,0.0002281621,0.0002150886,0.000014906,0.0004074821,0.0000143884,0.0002598119],"category_scores_gemma":[0.0001672224,0.0001226239,0.0002244044,0.0005059671,0.00005864499,0.00007108253,0.0003366542,0.0001190448,3.347884e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002886267,"about_ca_system_score_gemma":0.0009020192,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8018033,"about_ca_topic_score_gemma":0.5834749,"domain_scores_codex":[0.9984866,0.0001874659,0.0005370725,0.0003179531,0.000179436,0.0002915065],"domain_scores_gemma":[0.9963819,0.002814597,0.0002847521,0.000344133,0.0000983585,0.00007624747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004214538,0.001030222,0.7272642,0.000155799,0.00832918,0.000003150652,0.001914264,0.1413922,0.02218769,0.0000225885,0.0009290761,0.09255705],"study_design_scores_gemma":[0.01464072,0.0004092345,0.6316223,0.00005228013,0.001675677,7.918964e-7,0.002846544,0.2997867,0.03911688,0.000004923956,0.009657321,0.0001866416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929307,0.0007107649,0.0000519423,0.0005563466,0.0001763144,0.004471862,0.0009047799,0.000003988718,0.0001932612],"genre_scores_gemma":[0.9957838,0.001210114,0.0002240882,0.0001234964,0.00002142403,0.002487603,0.00007638274,0.00002198001,0.00005108067],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2183284,"threshold_uncertainty_score":0.7547488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3121637752","doi":"10.1007/s41669-021-00257-8","title":"The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Alberta Innovates; Sanofi","keywords":"Medicine; Secondary prevention; Dyslipidemia; Health care; Disease; Disease burden; Cardiovascular event; Internal medicine; Emergency medicine; Pediatrics","authors":[{"name":"Dat T. Tran","is_ca":true},{"name":"Dan Palfrey","is_ca":true},{"name":"Robert C. Welsh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03160288090312003,"gpt":0.3514413774480248,"spread":0.3198384965449048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002965679,0.0001449513,0.0004286986,0.00003722215,0.0002668743,0.00009693596,0.0002159858,0.00004771763,0.00007624603],"category_scores_gemma":[0.00008978523,0.0001143682,0.0004405864,0.0001116776,0.00003337302,0.0001587463,0.0001231403,0.0002513563,0.0000404879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002525856,"about_ca_system_score_gemma":0.0007517434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001500232,"about_ca_topic_score_gemma":0.0003881729,"domain_scores_codex":[0.9980648,0.0006292704,0.0003624165,0.0004555663,0.0001454723,0.0003425087],"domain_scores_gemma":[0.9986259,0.0000869002,0.00009701114,0.0006438547,0.0001789807,0.0003673663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002693282,0.0002821325,0.01077216,0.001409448,0.004200212,0.0002582337,0.0006586552,0.005035696,0.00001217044,0.001709349,0.002530857,0.9704378],"study_design_scores_gemma":[0.0408091,0.0002603499,0.05975332,0.0007606823,0.001756007,0.0001091634,0.001082031,0.008827553,0.0005709862,0.001443383,0.8840749,0.0005525512],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8745986,0.02815942,0.01170674,0.060644,0.001546815,0.02110604,0.0006296061,0.0001071021,0.001501663],"genre_scores_gemma":[0.9833321,0.010814,0.0008578296,0.001653615,0.0004832882,0.00174077,0.0003535893,0.00005522072,0.0007095556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9698852,"threshold_uncertainty_score":0.4663799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2601604409","doi":"10.1007/s41669-017-0018-3","title":"Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Cancer Care Ontario; St. Michael's Hospital","funders":"","keywords":"Consistency (knowledge bases); Activity-based costing; Drug pricing; Medicine; Political science; Actuarial science; Business; Accounting; Computer science","authors":[{"name":"Lisa Masucci","is_ca":true},{"name":"Jaclyn Beca","is_ca":true},{"name":"Mona Sabharwal","is_ca":false},{"name":"Jeffrey S. Hoch","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7627049803111466,"gpt":0.6465122802148523,"spread":0.1161927000962943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.06092061,0.0003992948,0.002178064,0.0004470343,0.001152179,0.0008677223,0.004409099,0.0001872414,0.006213479],"category_scores_gemma":[0.007163201,0.0004330615,0.0002295968,0.0001127994,0.0001639048,0.001498842,0.0008275709,0.0005242923,0.02458853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003692483,"about_ca_system_score_gemma":0.001455331,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2136718,"about_ca_topic_score_gemma":0.2466334,"domain_scores_codex":[0.9909664,0.00187243,0.004902886,0.001240157,0.00006752857,0.0009506467],"domain_scores_gemma":[0.9920203,0.002203264,0.003008382,0.002019284,0.00007283031,0.0006759147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005090741,0.0001186304,0.0209063,0.0002493706,0.000198283,0.00000848036,0.001727785,0.0008314507,0.000004631608,0.06842145,0.8982769,0.009205768],"study_design_scores_gemma":[0.001242482,0.00004914645,0.02670406,0.0002029666,0.00002995738,0.00001197572,0.0002343352,0.004777331,0.00001843604,0.01379673,0.9523559,0.0005766316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.03994649,0.01146493,0.0001792118,0.8765264,0.002639915,0.006362735,0.0009866722,0.00003887959,0.06185478],"genre_scores_gemma":[0.4714518,0.04123893,0.01543909,0.4538642,0.002659193,0.005503545,0.000291119,0.0002339196,0.009318239],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.4315053,"threshold_uncertainty_score":0.9998121,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2887988025","doi":"10.1007/s41669-018-0089-9","title":"Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Pharmaceuticals; Janssen Scientific Affairs","keywords":"Paliperidone Palmitate; Medicaid; Paliperidone; Schizophrenia (object-oriented programming); Medicine; Pharmacy; Medical costs; Health care; Emergency medicine; Demography; Psychiatry; Family medicine; Antipsychotic; Political science","authors":[{"name":"Bruno Émond","is_ca":true},{"name":"Kruti Joshi","is_ca":false},{"name":"Antoine C. El Khoury","is_ca":false},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Dominic Pilon","is_ca":true},{"name":"Neeta Tandon","is_ca":false},{"name":"Hela Romdhani","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05890968230085235,"gpt":0.3706249907799557,"spread":0.3117153084791033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003946456,0.0003087937,0.000590515,0.0002054417,0.0002882262,0.000240548,0.000336215,0.00008999998,0.0003975948],"category_scores_gemma":[0.0000563711,0.0002738682,0.00004029939,0.0003071266,0.000191388,0.0003948242,0.0001935607,0.0003021562,0.0000892397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003822001,"about_ca_system_score_gemma":0.0006897708,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008898764,"about_ca_topic_score_gemma":0.05173347,"domain_scores_codex":[0.9978579,0.0001325284,0.000490419,0.0007419183,0.0002492765,0.0005279669],"domain_scores_gemma":[0.9984402,0.0001746177,0.0001205521,0.0003705143,0.00015557,0.0007385339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1998152,0.001189586,0.1332603,0.0001900577,0.001412663,0.0007612169,0.01411468,0.0003659605,0.001227317,0.004088528,0.008807637,0.6347669],"study_design_scores_gemma":[0.154562,0.01429487,0.6333399,0.005594032,0.0009701544,0.0002096015,0.009376934,0.02477541,0.03800554,0.004832389,0.1106448,0.003394394],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796109,0.001270614,0.00004854324,0.01442707,0.00009973288,0.001974628,0.0004166553,0.0000492803,0.002102555],"genre_scores_gemma":[0.9901778,0.0005214938,0.005425805,0.002686454,0.0002897503,0.000309576,0.0004414288,0.00005303782,0.00009461462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6313725,"threshold_uncertainty_score":0.9999713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2956056819","doi":"10.1007/s41669-019-0154-z","title":"US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Major depressive disorder; Medicine; Depression (economics); Retrospective cohort study; Cohort; Treatment-resistant depression; Internal medicine; Confidence interval; Propensity score matching; Comorbidity; Rate ratio; Psychiatry; Mood","authors":[{"name":"Holly Szukis","is_ca":false},{"name":"Kruti Joshi","is_ca":false},{"name":"David Singer","is_ca":false},{"name":"John J. Sheehan","is_ca":false},{"name":"Jennifer W. Wu","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Paul E. Greenberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01090551635820826,"gpt":0.3006798630846841,"spread":0.2897743467264759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002060098,0.0004867,0.001116683,0.0001812754,0.00009724307,0.00008948417,0.0004186698,0.0001036914,0.001413918],"category_scores_gemma":[0.000008701259,0.0003555733,0.0001442939,0.00009567503,0.00006005341,0.0004179049,0.0002514557,0.0002595422,0.0002314532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003466551,"about_ca_system_score_gemma":0.0002638922,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0067775,"about_ca_topic_score_gemma":0.0002197439,"domain_scores_codex":[0.9977936,0.0001192361,0.0005272482,0.001018593,0.0001853462,0.0003560343],"domain_scores_gemma":[0.9981935,0.000113174,0.0004836973,0.000798871,0.000191377,0.000219374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01664353,0.002402687,0.9721169,0.000009755929,0.002105326,0.00002637292,0.0007394635,0.004421907,0.000167317,0.00003301149,0.0003328986,0.001000825],"study_design_scores_gemma":[0.02888948,0.005565857,0.956255,0.0001477732,0.0009348351,0.000004044604,0.001594443,0.003718611,0.002075002,0.00002060189,0.0003925831,0.000401807],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807875,0.0001030332,0.000003430968,0.00009738887,0.0003096923,0.007450242,0.0001850518,0.00005563956,0.01100801],"genre_scores_gemma":[0.9978755,0.00009056742,0.0001700362,0.00011525,0.0001125119,0.0003101089,0.0001720003,0.00009484677,0.001059153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01708801,"threshold_uncertainty_score":0.9998896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4321490951","doi":"10.1007/s41669-023-00396-0","title":"Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network; Hôpital Charles-Le Moyne; William Osler Health System","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Adjuvant; Lung cancer; Oncology; Internal medicine; Quality of life (healthcare); Disease; Cost effectiveness; Quality-adjusted life year; Cancer; Epidermal growth factor receptor","authors":[{"name":"Andre Verhoek","is_ca":false},{"name":"Parneet Cheema","is_ca":true},{"name":"Barbara Melosky","is_ca":false},{"name":"Benoit Samson","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Filippo de Marinis","is_ca":false},{"name":"Thomas John","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Bart Heeg","is_ca":false},{"name":"Nadia Van Dalfsen","is_ca":false},{"name":"Benjamin Bracke","is_ca":false},{"name":"Miguel Miranda","is_ca":false},{"name":"Simon Shaw","is_ca":false},{"name":"Daniel Moldaver","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04069752551216663,"gpt":0.4178555083762873,"spread":0.3771579828641207,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007992501,0.0001264213,0.0003525737,0.0001846498,0.00003576741,0.00001330447,0.0001239308,0.0000339566,0.0001596787],"category_scores_gemma":[0.00002567413,0.0001117911,0.00003719152,0.000304922,0.00003039902,0.0001945671,0.00006358088,0.00007907526,0.000007847606],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006673709,"about_ca_system_score_gemma":0.0008628453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002386582,"about_ca_topic_score_gemma":0.0002427065,"domain_scores_codex":[0.9988881,0.0001673188,0.000333683,0.0002591303,0.0001903574,0.0001614204],"domain_scores_gemma":[0.9987473,0.0001694858,0.0002521639,0.0001504374,0.0006147727,0.00006578083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00394994,0.001149589,0.9150576,0.0005506785,0.001326037,0.000008167262,0.003144466,0.04968358,0.006334423,0.00002152364,0.0003897311,0.01838427],"study_design_scores_gemma":[0.02452762,0.0002797331,0.8614466,0.0003950928,0.001320678,3.059752e-7,0.0001417089,0.03216359,0.07955601,0.00002711944,0.00001968656,0.0001218379],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908214,0.0001172843,0.00002567183,0.00006968183,0.0001354604,0.005958301,0.0003348959,0.000009507105,0.002527774],"genre_scores_gemma":[0.9978411,0.00004470105,0.00009234561,0.00005587193,0.00001510071,0.001226073,0.0006283596,0.00002765351,0.00006881492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07322159,"threshold_uncertainty_score":0.4558707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367175132","doi":"10.1007/s41669-023-00415-0","title":"Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis","year":2023,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Systematic review; Medicine; Critical appraisal; Checklist; Grey literature; MEDLINE; Nephropathy; Quality of life (healthcare); Economic evaluation; Health care; Family medicine; Intensive care medicine; Alternative medicine; Psychology; Nursing; Pathology; Political science","authors":[{"name":"Kenar D. Jhaveri","is_ca":false},{"name":"Mark Bensink","is_ca":false},{"name":"Martin Bunke","is_ca":false},{"name":"Jonathon A. Briggs","is_ca":false},{"name":"David M.W. Cork","is_ca":false},{"name":"Anushya Jeyabalan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08089463607554481,"gpt":0.4101879574652315,"spread":0.3292933213896867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009577875,0.000589437,0.005174519,0.0002797504,0.0001306797,0.0003350968,0.0003980934,0.000175136,0.0001292161],"category_scores_gemma":[0.0002334578,0.0004454527,0.0004240108,0.0001145039,0.0001321419,0.000254241,0.0005122064,0.0003067663,0.0001870744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001635316,"about_ca_system_score_gemma":0.0002954743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000872841,"about_ca_topic_score_gemma":0.000007480425,"domain_scores_codex":[0.9970316,0.0003591505,0.001626302,0.0006659663,0.00006583468,0.0002511538],"domain_scores_gemma":[0.9973343,0.0006122963,0.001240028,0.0004881092,0.00004342121,0.0002818262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004100122,0.00002649229,0.000004148345,0.9413848,0.001133575,0.00005827427,0.001096132,0.000001143218,0.000002059024,0.0004377876,0.003715122,0.05209945],"study_design_scores_gemma":[0.0006305608,0.00009986163,0.000006838437,0.4794076,0.01030439,0.000278699,0.0003149481,0.0003017837,0.000003113145,0.0001322262,0.5078721,0.0006478411],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001803375,0.9923252,6.948558e-7,0.00009634909,0.0002136414,0.005948135,0.0006793257,0.00002974495,0.0005265624],"genre_scores_gemma":[0.00009901653,0.9971983,0.00008393286,0.0001051582,0.0003227688,0.001157046,0.0001416229,0.0001061573,0.0007860136],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.504157,"threshold_uncertainty_score":0.9997997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3203942868","doi":"10.1007/s41669-021-00300-8","title":"Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Ezetimibe; Familial hypercholesterolemia; Dyslipidemia; Statin; Internal medicine; Quality-adjusted life year; Alirocumab; Cost effectiveness; Cholesterol; Disease; Lipoprotein","authors":[{"name":"Ahmed Alghamdi","is_ca":false},{"name":"Bander Balkhi","is_ca":false},{"name":"Abdulaziz Altowaijri","is_ca":false},{"name":"Nasser Alshehri","is_ca":false},{"name":"Lewis Ralph","is_ca":false},{"name":"Emily-Ruth Marriott","is_ca":false},{"name":"Michael Urbich","is_ca":false},{"name":"Fawaz Aljanad","is_ca":false},{"name":"Rima Aziziyeh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1132914764465246,"gpt":0.427569372084309,"spread":0.3142778956377844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002155097,0.0001137873,0.000951387,0.00009164144,0.00004046492,0.0000120706,0.0002705004,0.00004151361,0.00008945337],"category_scores_gemma":[0.00006937576,0.0000682609,0.0005393949,0.0003814038,0.00005795372,0.00005501674,0.00005404502,0.00006713874,7.190214e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001834508,"about_ca_system_score_gemma":0.0003142213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002621559,"about_ca_topic_score_gemma":0.0004295169,"domain_scores_codex":[0.9987509,0.0002653355,0.0004937162,0.0002219956,0.000116607,0.0001514143],"domain_scores_gemma":[0.9980753,0.0008131991,0.0002548712,0.0006805118,0.0001372075,0.00003887705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.008283414,0.005899205,0.2227013,0.002521927,0.06654343,0.00003765525,0.008066596,0.04457593,0.02057586,0.005838801,0.001125617,0.6138303],"study_design_scores_gemma":[0.03022382,0.001384534,0.5251201,0.000232654,0.02363998,0.00001856814,0.002070939,0.0352432,0.2816463,0.0004127377,0.09963451,0.0003726939],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920399,0.002347844,0.0006024463,0.0007835559,0.0001194045,0.003516259,0.0001603356,0.000002161396,0.0004280615],"genre_scores_gemma":[0.9976152,0.001119936,0.0002421874,0.0002712325,0.00007338559,0.0005813323,0.00005460185,0.0000123552,0.00002972416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6134576,"threshold_uncertainty_score":0.396303,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2752473968","doi":"10.1007/s41669-017-0051-2","title":"The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; University of Toronto; Cancer Care Ontario; University of Manitoba; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Retrospective cohort study; Cancer; Confidence interval; Propensity score matching; Internal medicine; Cohort; Primary tumor; Proportional hazards model; Cancer registry; Population; Oncology; Clinical trial; Surgery; Metastasis","authors":[{"name":"Malek B. Hannouf","is_ca":true},{"name":"Eric Winquist","is_ca":true},{"name":"Salaheddin M. Mahmud","is_ca":true},{"name":"Muriel Brackstone","is_ca":true},{"name":"Sisira Sarma","is_ca":true},{"name":"George Rodrigues","is_ca":true},{"name":"Peter K. Rogan","is_ca":true},{"name":"Jeffrey S. Hoch","is_ca":true},{"name":"Gregory S. Zaric","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03977007119584718,"gpt":0.4071142063706688,"spread":0.3673441351748216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001599228,0.0001631957,0.0008404999,0.00006982629,0.0001657195,0.0001309951,0.0003713364,0.00003115381,0.00006750933],"category_scores_gemma":[0.00003873636,0.0001365721,0.0001170101,0.00002554308,0.0001457138,0.0002619546,0.0002144723,0.0001428023,0.000004397995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007211111,"about_ca_system_score_gemma":0.0005276587,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02021926,"about_ca_topic_score_gemma":0.002990365,"domain_scores_codex":[0.9981377,0.0001323297,0.001032941,0.0004345669,0.0001067463,0.0001556838],"domain_scores_gemma":[0.9981472,0.0001764288,0.001025906,0.0004972004,0.00006651103,0.00008669286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008171581,0.0007728583,0.9936566,0.0000601115,0.000576716,0.000005560979,0.00008386934,0.0005027341,0.0005760962,0.0001401218,0.0001579186,0.002650236],"study_design_scores_gemma":[0.007514337,0.0001605608,0.9861963,0.00005404663,0.0007443528,0.000002059394,0.00005944458,0.003375438,0.001494777,0.0002520677,0.00003288167,0.0001137424],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944242,0.000315065,0.000005762677,0.001273906,0.0004087349,0.003104213,0.0001346551,0.000005229831,0.0003281992],"genre_scores_gemma":[0.9979695,0.001062652,0.0001335803,0.0001485623,0.00008354813,0.0004547634,0.00005525997,0.00002498229,0.00006714822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01722889,"threshold_uncertainty_score":0.9863052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3168701893","doi":"10.1007/s41669-021-00275-6","title":"Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; University Health Network","funders":"Addis Ababa University","keywords":"Dolutegravir; Efavirenz; Human immunodeficiency virus (HIV); Medicine; Virology; Tenofovir; Second line; Pediatrics; Antiretroviral therapy; First line; Internal medicine; Viral load","authors":[{"name":"Yared Belete Belay","is_ca":false},{"name":"Eskinder Eshetu Ali","is_ca":false},{"name":"Karen Y. Chung","is_ca":true},{"name":"Gebremedhin Beedemariam Gebretekle","is_ca":true},{"name":"Beate Sander","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05826420296885351,"gpt":0.3741730334568439,"spread":0.3159088304879903,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003485109,0.0003584144,0.001169058,0.0005526785,0.0000570821,0.00004315532,0.0002638506,0.0001224108,0.001202327],"category_scores_gemma":[0.0001046672,0.0003414692,0.0002815435,0.0009008349,0.00005999339,0.00017538,0.0001728336,0.0002068237,0.0001058278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001281171,"about_ca_system_score_gemma":0.000807315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002455124,"about_ca_topic_score_gemma":0.0114957,"domain_scores_codex":[0.9976381,0.0001632494,0.000903931,0.0007171448,0.0001712132,0.0004063641],"domain_scores_gemma":[0.998493,0.0003171538,0.0002475684,0.0005482446,0.0001655762,0.0002285166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005740146,0.005087597,0.9716063,0.00005834813,0.003040949,0.0002080413,0.00168354,0.001330325,0.0000554997,0.0001855449,0.0006046874,0.01039906],"study_design_scores_gemma":[0.2422275,0.001858099,0.5576488,0.0004837229,0.01079532,0.000005603702,0.001551153,0.07815851,0.06347983,0.0001988983,0.04188877,0.001703733],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906979,0.00008077891,0.0000136218,0.002968945,0.000177221,0.001636544,0.0003009892,0.00001752813,0.00410653],"genre_scores_gemma":[0.9914562,0.0004819476,0.001804869,0.0005633025,0.00002168534,0.0003873361,0.002273007,0.00003181143,0.00297986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4139574,"threshold_uncertainty_score":0.9999037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125780982","doi":"10.1007/s41669-020-00244-5","title":"An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation Study","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; Simon Fraser University; Vancouver Coastal Health","funders":"Health Research Board","keywords":"Valuation (finance); EQ-5D; Attendance; Irish; Latent class model; Discrete choice; Actuarial science; Quality-adjusted life year; Health care; Psychology; Econometrics; Medicine; Computer science; Health related quality of life; Economics; Machine learning; Cost effectiveness; Risk analysis (engineering); Disease","authors":[{"name":"Edel Doherty","is_ca":true},{"name":"Anna Hobbins","is_ca":false},{"name":"David G. T. Whitehurst","is_ca":true},{"name":"Ciarán O’Neill","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8063207396074529,"gpt":0.5751746631831023,"spread":0.2311460764243506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01646726,0.0003709892,0.0009509805,0.0001374233,0.0007715189,0.001227908,0.002334494,0.0001065918,0.001297873],"category_scores_gemma":[0.001237238,0.0004359043,0.00009391175,0.0002199528,0.00005997385,0.00624946,0.0008497511,0.000328587,0.001667224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001389812,"about_ca_system_score_gemma":0.0007053504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005890436,"about_ca_topic_score_gemma":0.001143168,"domain_scores_codex":[0.9932004,0.001019961,0.003406157,0.001678609,0.0002326961,0.0004622127],"domain_scores_gemma":[0.9939018,0.001472434,0.002269703,0.001897821,0.0002169915,0.0002412116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0006140036,0.006707315,0.297475,0.0001933464,0.003222496,0.00001797427,0.03716125,0.2123659,0.001909196,0.01769462,0.4207627,0.001876261],"study_design_scores_gemma":[0.007679837,0.0002678228,0.05249239,0.0001216417,0.0001202707,0.000004851413,0.0151067,0.8192431,0.00078333,0.007700838,0.09494832,0.00153091],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9343653,0.0009371386,0.01534084,0.03366689,0.002572282,0.004095157,0.007038669,0.00006255804,0.001921144],"genre_scores_gemma":[0.9666037,0.0001626219,0.002966597,0.02378229,0.001968144,0.0004752168,0.003783383,0.0000897786,0.0001682811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6068772,"threshold_uncertainty_score":0.9998093,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3097148862","doi":"10.1007/s41669-020-00235-6","title":"Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pharmacoeconomics; Health technology; Excellence; Economic evaluation; Nice; Medicine; Health economics; Health care; Stakeholder; Transparency (behavior); Family medicine; Economic growth; Political science; Public relations; Economics; Intensive care medicine","authors":[{"name":"Akira Yuasa","is_ca":false},{"name":"Naohiro Yonemoto","is_ca":false},{"name":"Sven Demiya","is_ca":false},{"name":"Chihiro Foellscher","is_ca":false},{"name":"Shunya Ikeda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5166002091916603,"gpt":0.5059722978757282,"spread":0.0106279113159321,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006369479,0.000258238,0.001529507,0.0003694985,0.0001479661,0.0001379731,0.0008124187,0.0001408549,0.0009617099],"category_scores_gemma":[0.0005513366,0.0003484336,0.00007535584,0.0002896014,0.0001936596,0.0009812863,0.000273101,0.0002798545,0.0003248944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001137351,"about_ca_system_score_gemma":0.0009786767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002322225,"about_ca_topic_score_gemma":0.000224168,"domain_scores_codex":[0.9939466,0.0002852352,0.004573954,0.0006904619,0.00006105375,0.0004427461],"domain_scores_gemma":[0.9954744,0.000538079,0.003293215,0.0003432251,0.00005208854,0.0002990083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004288541,0.00006552253,0.6515557,0.0006363741,0.0001981938,0.000001143167,0.009241369,0.0004866772,0.0002644444,0.1381637,0.1992478,0.00009619105],"study_design_scores_gemma":[0.01665651,0.001061009,0.07675262,0.0004086859,0.00005215111,0.000009772261,0.03819569,0.06149787,0.011959,0.08859296,0.7013544,0.003459273],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7497206,0.002167734,0.0005945691,0.2417171,0.0003551876,0.001829774,0.001719708,0.00004794838,0.001847456],"genre_scores_gemma":[0.9507295,0.0007577284,0.003043464,0.04490676,0.00006968532,0.0001478756,0.0002139296,0.00004370594,0.00008729401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5748031,"threshold_uncertainty_score":0.9999515,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388790771","doi":"10.1007/s41669-023-00453-8","title":"Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Confidence interval; Incidence (geometry); Intensive care unit; Pediatrics; Emergency medicine; Diagnosis code; Internal medicine; Population","authors":[{"name":"Hilary M. DuBrock","is_ca":false},{"name":"Hayley D. Germack","is_ca":false},{"name":"Marjolaine Gauthier‐Loiselle","is_ca":true},{"name":"Jörg Linder","is_ca":false},{"name":"Ambika Satija","is_ca":false},{"name":"Ameur M. Manceur","is_ca":true},{"name":"Martin Cloutier","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Sumeet Panjabi","is_ca":false},{"name":"Robert P. Frantz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03449138985864929,"gpt":0.3230252596315598,"spread":0.2885338697729105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002128104,0.0002015347,0.000556425,0.0002907389,0.00005725338,0.00003204058,0.0003097791,0.00006163998,0.0006608179],"category_scores_gemma":[0.00001627962,0.0001685326,0.0000699568,0.0001530803,0.00005951481,0.0003370655,0.0003445947,0.0001375271,0.0005850751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001775917,"about_ca_system_score_gemma":0.0001948077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001617131,"about_ca_topic_score_gemma":0.0000407811,"domain_scores_codex":[0.9986055,0.00004029879,0.000416107,0.0004301465,0.0001238987,0.0003840386],"domain_scores_gemma":[0.9991317,0.0001057101,0.0001213065,0.0003296661,0.00006107672,0.0002505666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01440158,0.002037315,0.9475387,0.00007220899,0.0006713385,0.001624917,0.00008015369,0.0007368358,0.002453479,0.00002821261,0.01671212,0.01364309],"study_design_scores_gemma":[0.02622888,0.001250296,0.9460457,0.000165865,0.0002070986,0.00006128863,0.0001127172,0.01337719,0.003572998,0.0002119957,0.00832039,0.0004456048],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995637,0.00004049938,2.227784e-7,0.001157055,0.0001880689,0.001433262,0.0002570616,0.00003020687,0.001256603],"genre_scores_gemma":[0.9978322,0.0004580625,0.0001081956,0.0003470296,0.00008690109,0.0002050636,0.0006484587,0.00004571185,0.0002683573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01319748,"threshold_uncertainty_score":0.7520151,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2954548710","doi":"10.1007/s41669-019-0156-x","title":"The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation Model","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Diabetes mellitus; Absolute risk reduction; United Kingdom Prospective Diabetes Study; Type 2 diabetes; Clinical trial; Confidence interval; Internal medicine","authors":[{"name":"Zhuo T. Su","is_ca":false},{"name":"José Bartelt-Hofer","is_ca":false},{"name":"Stephen Brown","is_ca":false},{"name":"Elisheva Lew","is_ca":false},{"name":"Luc Sauriol","is_ca":true},{"name":"Lieven Annemans","is_ca":false},{"name":"Daniel Grima","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0777691001279494,"gpt":0.3536708675563976,"spread":0.2759017674284482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003572777,0.0001504174,0.0004543145,0.00007833785,0.00008409789,0.00006893613,0.0002807076,0.00003827471,0.000008705424],"category_scores_gemma":[0.00002941329,0.0001038099,0.00008537834,0.0001917679,0.00005327855,0.0004193496,0.0001695918,0.0001136189,0.00001402142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009693914,"about_ca_system_score_gemma":0.00007148593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002063619,"about_ca_topic_score_gemma":0.00003790151,"domain_scores_codex":[0.9988241,0.00009727629,0.0004717917,0.0002564521,0.0001659458,0.0001844503],"domain_scores_gemma":[0.9985448,0.0002868647,0.0002629436,0.0004914944,0.0003556674,0.00005819543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0001857567,0.0001156736,0.06913169,0.00003341163,0.000176028,9.161171e-9,0.0003480924,0.9248178,0.0001105415,0.00003594729,0.00001850529,0.005026537],"study_design_scores_gemma":[0.001807676,0.0001085681,0.06467211,0.0001086801,0.0001191776,1.43929e-8,0.00001257585,0.930522,0.002287555,0.00006945718,0.0001765624,0.000115681],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913978,0.00004482607,0.005306516,0.00009982482,0.0001120208,0.002928424,0.00004049704,0.00001015796,0.00005993387],"genre_scores_gemma":[0.9967971,0.000007019275,0.002770743,0.0002126857,0.00001860498,0.00004302923,0.0001100505,0.00002332449,0.00001747761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005704135,"threshold_uncertainty_score":0.4233245,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360601194","doi":"10.1007/s41669-023-00406-1","title":"Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Novartis","keywords":"Purchasing; Discounting; Health care; Thematic analysis; Value-Based Purchasing; Business; Reimbursement; Actuarial science; Public economics; Marketing; Economics; Qualitative research; Economic growth; Finance","authors":[{"name":"Mackenzie Mills","is_ca":false},{"name":"Panos Kanavos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5573958734861583,"gpt":0.5653476281504209,"spread":0.007951754664262678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01621662,0.0002187186,0.0009179485,0.0002640407,0.0003489135,0.0001836259,0.0007395447,0.0001002478,0.0006787314],"category_scores_gemma":[0.001222063,0.0002236309,0.00005769156,0.000160768,0.0001603982,0.0008393683,0.0003365826,0.0002838911,0.001147275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001210152,"about_ca_system_score_gemma":0.0005753728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003597806,"about_ca_topic_score_gemma":0.0002359645,"domain_scores_codex":[0.9957008,0.0005663086,0.002453448,0.0008476579,0.00007477941,0.0003570254],"domain_scores_gemma":[0.9933649,0.00330728,0.002485841,0.0005976887,0.00011071,0.0001335906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003830577,0.0007231098,0.4242747,0.001249341,0.001108085,0.000004733523,0.09019208,0.001939369,0.0005415409,0.3519782,0.122945,0.004660749],"study_design_scores_gemma":[0.00702233,0.001009107,0.5786026,0.0007856156,0.000111987,0.000009108713,0.05650275,0.1122724,0.001714237,0.01797353,0.222192,0.001804404],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6852817,0.002626851,0.0003354292,0.3073298,0.0005467428,0.00231746,0.0006234201,0.00004804506,0.0008905825],"genre_scores_gemma":[0.9766548,0.006719057,0.003318729,0.01202489,0.0003464035,0.0004686443,0.00006990724,0.00004672583,0.0003508649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3340047,"threshold_uncertainty_score":0.9996305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016073506","doi":"10.1007/s41669-020-00215-w","title":"Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health","funders":"Astellas Pharma Global Development; Astellas Pharma","keywords":"Anticholinergic; Medicine; Cohort; Overactive bladder; Emergency medicine; Cohort study; Health care; Anticholinergic agents; Physical therapy; Internal medicine; Alternative medicine","authors":[{"name":"Greta Lozano‐Ortega","is_ca":true},{"name":"Carol R. Schermer","is_ca":false},{"name":"David Walker","is_ca":false},{"name":"Shelagh M. Szabo","is_ca":true},{"name":"Basia Rogula","is_ca":true},{"name":"Alison Deighton","is_ca":true},{"name":"Katherine Gooch","is_ca":false},{"name":"Noll L. Campbell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03060497513465011,"gpt":0.3536645339930266,"spread":0.3230595588583764,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003440835,0.000229303,0.0004993572,0.00008512077,0.00009356181,0.0001280745,0.0001640929,0.00008730472,0.0001779581],"category_scores_gemma":[0.00003238896,0.0001684194,0.0000282435,0.0002397276,0.00003519285,0.0005729907,0.0001566634,0.0006739218,0.00003157876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004427431,"about_ca_system_score_gemma":0.0003898535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004535072,"about_ca_topic_score_gemma":0.0007564297,"domain_scores_codex":[0.9986098,0.0001462719,0.0002833757,0.0004630575,0.0001388326,0.0003586832],"domain_scores_gemma":[0.9989567,0.0002492054,0.0001886656,0.0001332626,0.0001391865,0.0003329805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01650484,0.0004016247,0.917654,0.000252862,0.002188376,0.0002290512,0.04625146,0.004589336,0.001716522,0.0001404158,0.003719729,0.006351776],"study_design_scores_gemma":[0.08104433,0.008733042,0.6431623,0.0006182796,0.0006536341,0.0003901701,0.01587789,0.1779048,0.01519036,0.0005400092,0.0536154,0.002269716],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9421545,0.0002825538,0.00001757963,0.05099479,0.00002389533,0.001830382,0.00008072645,0.00002565292,0.004589901],"genre_scores_gemma":[0.9938639,0.0006505426,0.00010367,0.00464286,0.00009635443,0.00006096548,0.0001517387,0.00004665197,0.000383356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2744917,"threshold_uncertainty_score":0.6867945,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308254443","doi":"10.1007/s41669-022-00375-x","title":"A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"ABB (Canada); Foothills Medical Centre","funders":"AbbVie","keywords":"Obinutuzumab; Venetoclax; Medicine; Chlorambucil; Rituximab; Bendamustine; Internal medicine; Fludarabine; Chronic lymphocytic leukemia; Ibrutinib; Oncology; Population; Ofatumumab; Cyclophosphamide; Leukemia; Chemotherapy; Lymphoma","authors":[{"name":"Anuja Chatterjee","is_ca":false},{"name":"Gijs van de Wetering","is_ca":false},{"name":"Ron Goeree","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Anne Marie Desbois","is_ca":true},{"name":"Stéphane Barakat","is_ca":true},{"name":"Beenish S. Manzoor","is_ca":false},{"name":"Kavita Sail","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04922340262774139,"gpt":0.3689317120683685,"spread":0.3197083094406271,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00122983,0.0002502367,0.001059988,0.0005597911,0.00009043021,0.0000374924,0.0005993592,0.00004473836,0.001150405],"category_scores_gemma":[0.0000831369,0.000269461,0.00009500099,0.001169,0.00009036573,0.0001407239,0.000767033,0.0003641324,0.00000445322],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.7097142,"about_ca_system_score_gemma":0.3051045,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9793026,"about_ca_topic_score_gemma":0.8743691,"domain_scores_codex":[0.9975809,0.0002911591,0.0006828629,0.000645966,0.0002743404,0.0005247724],"domain_scores_gemma":[0.9983527,0.0007158234,0.0001932219,0.0004825981,0.00005156786,0.0002040824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.004115146,0.00003813261,0.005819956,0.000307809,0.0009008592,0.0003419507,0.000431173,0.9822661,0.000561547,0.0001122432,0.0001069985,0.004998039],"study_design_scores_gemma":[0.04388485,0.0004320919,0.00980232,0.00006857964,0.0002556028,0.00008343171,0.0001582852,0.9405372,0.001572416,0.0001276597,0.002817429,0.0002601136],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939042,0.001118043,0.000001948829,0.00008040199,0.00009127591,0.004116302,0.0001123476,0.000008394027,0.000567104],"genre_scores_gemma":[0.9964226,0.0009889334,0.0000127826,0.0004506516,0.00002784215,0.001839851,0.0001060234,0.00004201836,0.0001092378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4046097,"threshold_uncertainty_score":0.9999757,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2755337532","doi":"10.1007/s41669-017-0057-9","title":"Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; Health care; Pharmacist; Tuberculosis; Indirect costs; Family medicine; Pulmonary tuberculosis; Total cost; Emergency medicine; Pharmacy","authors":[{"name":"Pimwara Tanvejsilp","is_ca":true},{"name":"Mark Loeb","is_ca":true},{"name":"Jonathan Dushoff","is_ca":true},{"name":"Feng Xie","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1015451370450879,"gpt":0.4188376856994597,"spread":0.3172925486543717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001997037,0.0001594233,0.001225319,0.000145819,0.000072294,0.00001656296,0.0004255371,0.00009297905,0.0001778745],"category_scores_gemma":[0.0002990088,0.0001305614,0.00006124434,0.00003011143,0.0002404599,0.0002715153,0.0003802311,0.0002522854,0.000003780216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001027781,"about_ca_system_score_gemma":0.0002452817,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0138901,"about_ca_topic_score_gemma":0.001260028,"domain_scores_codex":[0.9979518,0.0002936404,0.001009941,0.0003258123,0.0001193051,0.0002994812],"domain_scores_gemma":[0.9979747,0.0002562161,0.0009323938,0.0004729925,0.00006627489,0.0002974286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002881967,0.0004307928,0.9853104,0.0002630537,0.0003328498,0.000003214317,0.0002557263,0.000008179083,0.0003852831,0.00003672783,0.002310918,0.007780867],"study_design_scores_gemma":[0.005650313,0.0003010798,0.9915842,0.000121837,0.00002867242,0.000001572016,0.00006177594,0.0001760315,0.001410612,0.00008113211,0.0004661834,0.0001166251],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905235,0.0008766065,5.698078e-7,0.003175532,0.0001011395,0.001143814,0.000261878,0.00000425712,0.003912711],"genre_scores_gemma":[0.9978696,0.001128542,0.0001299329,0.000628032,0.00002248239,0.0000338092,0.0001359308,0.00001912429,0.0000326031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01263008,"threshold_uncertainty_score":0.9926765,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3154274729","doi":"10.1007/s41669-021-00263-w","title":"Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; MEDLINE; Economic evaluation; Oncology; Family medicine; Internal medicine; Medical physics; Pathology","authors":[{"name":"Graeme Ball","is_ca":true},{"name":"Mitchell Levine","is_ca":true},{"name":"Lehana Thabane","is_ca":true},{"name":"Jean‐Éric Tarride","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.670614332465464,"gpt":0.6442023617784887,"spread":0.02641197068697532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.09903752,0.0002995557,0.002852704,0.0004610291,0.0001049574,0.0002104654,0.0007401783,0.0002141377,0.001631423],"category_scores_gemma":[0.005877104,0.0004148238,0.0001221394,0.0002154355,0.00009884848,0.00102116,0.0005014692,0.0002594401,0.000547856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002335737,"about_ca_system_score_gemma":0.001698133,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009779416,"about_ca_topic_score_gemma":0.005335125,"domain_scores_codex":[0.9863282,0.005040264,0.007044858,0.00103835,0.00007251927,0.0004757616],"domain_scores_gemma":[0.9908583,0.004279057,0.003697256,0.0007401526,0.0001893422,0.0002358832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0008727038,0.00269776,0.5184164,0.04512817,0.00425501,0.00003285194,0.02350688,0.02342147,0.0007292224,0.3148028,0.04726591,0.01887085],"study_design_scores_gemma":[0.02070106,0.0004027891,0.1906244,0.002238296,0.0003248187,0.0001478272,0.005296532,0.6693891,0.001933078,0.07989773,0.0262129,0.002831424],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8974152,0.02258815,0.004529456,0.01857608,0.003838285,0.00896978,0.001924119,0.00005549885,0.04210347],"genre_scores_gemma":[0.9458194,0.002090406,0.03965331,0.009668724,0.0002198883,0.001420287,0.0003419073,0.0001327433,0.0006533149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6459677,"threshold_uncertainty_score":0.9998304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2581612511","doi":"10.1007/s41669-017-0011-x","title":"Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Astellas Pharma Global Development; Astellas Pharma Europe; Astellas Pharma; Canadian Urological Association; Duchesnay; Pfizer","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Solifenacin; Medicine; Urology; Cohort; Internal medicine","authors":[{"name":"Jameel Nazir","is_ca":false},{"name":"Malin Berling","is_ca":false},{"name":"Charles McCrea","is_ca":false},{"name":"Francis Fatoye","is_ca":false},{"name":"Sally Bowditch","is_ca":false},{"name":"Zalmaï Hakimi","is_ca":false},{"name":"Adrian Wagg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1589304446283486,"gpt":0.5192326041491452,"spread":0.3603021595207966,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005598012,0.0001442564,0.0003830746,0.00005213814,0.0001594764,0.00009806072,0.0007539214,0.00003858863,0.0004994124],"category_scores_gemma":[0.00002142084,0.00008256004,0.0002430248,0.00001510621,0.0001340426,0.0002337769,0.0001293567,0.0001064668,0.00001523717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003024018,"about_ca_system_score_gemma":0.00049351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005453008,"about_ca_topic_score_gemma":0.0003134447,"domain_scores_codex":[0.999148,0.00004970907,0.0003051586,0.0002084612,0.00005436514,0.0002343085],"domain_scores_gemma":[0.9981166,0.0008365727,0.0002665601,0.0006849784,0.00003801007,0.00005727632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1806136,0.007175772,0.3728373,0.0004017968,0.02106953,0.00008298884,0.0303879,0.008538761,0.00940303,0.003533005,0.04440452,0.3215518],"study_design_scores_gemma":[0.10779,0.02313493,0.6707538,0.00008602317,0.001869581,0.00005450952,0.002611003,0.05513667,0.05183415,0.001149434,0.08481139,0.0007685757],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838906,0.0003536222,0.000003363732,0.001625247,0.0002135195,0.002561723,0.0003302307,0.000001829116,0.01101988],"genre_scores_gemma":[0.9950272,0.004304728,0.00004792422,0.00005944557,0.0001311744,0.0001543808,0.00002898664,0.00001819421,0.000227912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3207832,"threshold_uncertainty_score":0.8243353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225004644","doi":"10.1007/s41669-022-00331-9","title":"Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; Population Health Research Institute; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Medicine; Tofacitinib; Golimumab; Ustekinumab; Ulcerative colitis; Infliximab; Adalimumab; Internal medicine; Disease","authors":[{"name":"Elisabetta Fenu","is_ca":false},{"name":"Vasily Lukyanov","is_ca":false},{"name":"Annabel Acs","is_ca":false},{"name":"Xenia Radu","is_ca":false},{"name":"Stephanie Stypa","is_ca":true},{"name":"Aren Fischer","is_ca":true},{"name":"John K. Marshall","is_ca":true},{"name":"Mark Oppe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.023059148200213,"gpt":0.3108708866433255,"spread":0.2878117384431125,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001915521,0.0001111262,0.0002371559,0.00002345677,0.00004886609,0.000006701345,0.0002935041,0.00001582519,0.00008058352],"category_scores_gemma":[0.00001169007,0.0001285466,0.00005797929,0.00002551739,0.00002855374,0.000004814948,0.0001634787,0.00002767617,3.977001e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008412162,"about_ca_system_score_gemma":0.001689186,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1733308,"about_ca_topic_score_gemma":0.3700286,"domain_scores_codex":[0.9991375,0.000165479,0.0002488662,0.0002359843,0.00003696727,0.0001752312],"domain_scores_gemma":[0.9995125,0.00006053606,0.0001499184,0.0001756104,0.00004680161,0.00005463793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2533408,0.00306834,0.1053799,0.001522298,0.002687319,0.001577517,0.001590183,0.2957427,0.2853504,0.00547363,0.01338921,0.03087764],"study_design_scores_gemma":[0.03135584,0.002300237,0.1171165,0.00004552856,0.00014513,0.0001027938,0.001126924,0.007563861,0.7597343,0.0004750227,0.07910313,0.0009307169],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948163,0.00005451799,0.00003036909,0.00003057788,0.0001775709,0.002008783,0.002313679,9.721439e-7,0.0005672532],"genre_scores_gemma":[0.9983182,0.00005356915,0.00004970385,0.00009698474,0.00001956076,0.001104972,0.0002385239,0.00001866412,0.00009983651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4743839,"threshold_uncertainty_score":0.8321741,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766103705","doi":"10.1007/s41669-018-0112-1","title":"Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Medicine; Pembrolizumab; Regimen; Internal medicine; Oncology; Progression-free survival; Cost effectiveness; Immunotherapy; Cancer; Chemotherapy","authors":[{"name":"Peter Quon","is_ca":false},{"name":"Ying Xiao","is_ca":false},{"name":"Sonja Sorensen","is_ca":false},{"name":"Amir Abbas Tahami Monfared","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02394847874053593,"gpt":0.3310521936035749,"spread":0.3071037148630389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002662743,0.0001444538,0.0003724592,0.00007040766,0.00003021802,0.00001619638,0.0001466722,0.00002720316,0.0007500999],"category_scores_gemma":[0.000005731268,0.0001322627,0.00004619176,0.00003809637,0.00001350775,0.0002279716,0.00002770875,0.00003680282,0.00001283041],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006962179,"about_ca_system_score_gemma":0.003071001,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4475948,"about_ca_topic_score_gemma":0.6351725,"domain_scores_codex":[0.9990692,0.00002681521,0.0003760255,0.0002688596,0.0000979092,0.0001612029],"domain_scores_gemma":[0.9993241,0.0000711914,0.0002495631,0.0002071138,0.00009636454,0.00005169511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09628028,0.001545083,0.4573766,0.0002598274,0.001539133,0.000002094671,0.0007920453,0.03975776,0.0009253995,0.0001890993,0.001057064,0.4002756],"study_design_scores_gemma":[0.4766383,0.009059108,0.2624628,0.0002862927,0.0007046829,0.000006469616,0.0004823607,0.1969949,0.02438547,0.0002858441,0.02788225,0.0008114814],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992232,0.0001220569,0.000002220145,0.0004613411,0.0003543313,0.004900373,0.0001398477,0.000003932716,0.001783845],"genre_scores_gemma":[0.9985167,0.0001506462,0.00008926621,0.0002595723,0.0000180775,0.0003542902,0.0003466203,0.00002431889,0.0002404659],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3994642,"threshold_uncertainty_score":0.9968499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2617296499","doi":"10.1007/s41669-017-0030-7","title":"Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Programs for Assessment of Technology in Health Research Institute; Impact","funders":"","keywords":"Bevacizumab; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer; Chemotherapy","authors":[{"name":"Graeme Ball","is_ca":true},{"name":"Feng Xie","is_ca":true},{"name":"Jean-Eric Tarride","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1083930942929834,"gpt":0.4342703966696648,"spread":0.3258773023766814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000354205,0.0001607109,0.0006103609,0.00005622552,0.00007263136,0.00003411863,0.0002596756,0.00002889835,0.0008948256],"category_scores_gemma":[0.00001574292,0.0001505158,0.00007628076,0.00001273436,0.00002654165,0.0001498007,0.00006115,0.00002541641,0.000002306081],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006189858,"about_ca_system_score_gemma":0.005767173,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8744409,"about_ca_topic_score_gemma":0.9341331,"domain_scores_codex":[0.998836,0.00003039003,0.0005429609,0.0003125464,0.0000925074,0.0001855966],"domain_scores_gemma":[0.9986935,0.00007441921,0.0005906151,0.0004596557,0.00008621297,0.0000955541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006421968,0.001229947,0.2345958,0.0002577069,0.002055895,0.00001013512,0.0006650558,0.007985532,0.001419571,0.001279232,0.003350389,0.7407288],"study_design_scores_gemma":[0.09535861,0.001732263,0.688405,0.0004999802,0.002817977,0.000004710377,0.0002445338,0.07582735,0.1059017,0.000807295,0.02782882,0.0005716948],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988376,0.0008480296,0.000001439477,0.002641619,0.0006093784,0.003107551,0.001578313,0.000001830578,0.0028358],"genre_scores_gemma":[0.9973195,0.001006194,0.0002360865,0.00005771512,0.0000991513,0.001144304,0.00005910022,0.00002064505,0.00005726535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7401571,"threshold_uncertainty_score":0.9998692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405460373","doi":"10.1007/s41669-024-00537-z","title":"Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations","year":2024,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"F. Hoffmann-La Roche; Roche","keywords":"Resource (disambiguation); Management science; Psychological intervention; Health care; Health technology; Set (abstract data type); Risk analysis (engineering); Economic evaluation; Computer science; Intervention (counseling); Knowledge management; Process management; Environmental economics; Business; Medicine; Economics; Nursing; Microeconomics","authors":[{"name":"Praveen Thokala","is_ca":false},{"name":"Henrique Duarte","is_ca":false},{"name":"Stuart Wright","is_ca":false},{"name":"Don Husereau","is_ca":true},{"name":"Isabelle Durand‐Zaleski","is_ca":false},{"name":"Peter Lindgren","is_ca":false},{"name":"Roelien Postema","is_ca":false},{"name":"Gerardo Machnicki","is_ca":false},{"name":"Louis P. Garrison","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7165022102291071,"gpt":0.6053250367160649,"spread":0.1111771735130422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.05081539,0.0003421028,0.001553184,0.0005818629,0.0003640802,0.00107517,0.0004761246,0.0001551103,0.003725945],"category_scores_gemma":[0.002110081,0.0004490659,0.0001208274,0.0001676227,0.0002526085,0.001601497,0.0003931996,0.0004657416,0.001951544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001642525,"about_ca_system_score_gemma":0.001137084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002098902,"about_ca_topic_score_gemma":0.0006968215,"domain_scores_codex":[0.9907072,0.001682276,0.00572278,0.001265338,0.00005830203,0.0005640907],"domain_scores_gemma":[0.9925254,0.005032133,0.001587995,0.0004686287,0.00002527427,0.0003605644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.00001600944,0.00006125861,0.004359449,0.0005381491,0.0001360297,0.000006840576,0.00163125,0.002600465,0.000008160479,0.9398504,0.04692439,0.003867584],"study_design_scores_gemma":[0.002762264,0.0001377063,0.004997639,0.0006228124,0.0000240703,0.0001339806,0.001564489,0.1897468,0.00002337532,0.5281447,0.2707374,0.001104782],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1471446,0.09510174,0.01028377,0.6582909,0.004108967,0.01223888,0.004044501,0.0005347593,0.0682519],"genre_scores_gemma":[0.8590574,0.004344511,0.049104,0.08446541,0.0007803363,0.001089468,0.0002482646,0.0001561751,0.0007544819],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7119128,"threshold_uncertainty_score":0.9999618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4366351945","doi":"10.1007/s41669-023-00407-0","title":"Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Osimertinib; Medicine; Lung cancer; Health care; Population; Oncology; Disease; Internal medicine; Chemotherapy; Cancer; Intensive care medicine; Epidermal growth factor receptor; Erlotinib; Environmental health","authors":[{"name":"Julie Vanderpoel","is_ca":false},{"name":"Bruno Émond","is_ca":true},{"name":"Isabelle Ghelerter","is_ca":true},{"name":"Katherine Milbers","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Lorie Ellis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04130728605065252,"gpt":0.3808028667329686,"spread":0.3394955806823161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002162534,0.0002250671,0.0003883217,0.0004792244,0.0001544403,0.00008392028,0.0001586484,0.00004266504,0.00002320492],"category_scores_gemma":[0.000005799835,0.0001671505,0.00003359868,0.001427633,0.00003098513,0.0002508307,0.00003504695,0.0001269125,0.00000183735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001481434,"about_ca_system_score_gemma":0.0002667782,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01934001,"about_ca_topic_score_gemma":0.03413394,"domain_scores_codex":[0.9986684,0.0001425833,0.0003534024,0.0004531905,0.00008896483,0.000293492],"domain_scores_gemma":[0.9992077,0.000128247,0.0001802523,0.0002462289,0.0001069248,0.0001306082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001239442,0.0004470969,0.8289229,0.00005957716,0.0002899544,0.00001920463,0.008741718,0.1514164,0.000006100652,0.000001493157,0.00004842103,0.008807746],"study_design_scores_gemma":[0.01701519,0.0005737666,0.7739607,0.0001884887,0.0006082999,3.152757e-7,0.002416008,0.2039628,0.0002249534,0.000004267454,0.0008430051,0.0002021343],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942242,0.0002026571,0.00004641763,0.001785689,0.00003713007,0.003131394,0.0004520225,0.00002889723,0.00009159307],"genre_scores_gemma":[0.9923158,0.001229983,0.0001522159,0.001187952,0.00001316726,0.0008379715,0.004162602,0.00003634302,0.00006399913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05496213,"threshold_uncertainty_score":0.9871903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323921312","doi":"10.1007/s41669-023-00400-7","title":"Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; University of Calgary; Alberta Health; University of Alberta; Institute of Health Economics","funders":"University of Alberta; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Alberta Health Services","keywords":"Randomized controlled trial; Medicine; COPD; Bundle; Emergency medicine; Internal medicine","authors":[{"name":"Charles Yan","is_ca":true},{"name":"Jeff Round","is_ca":true},{"name":"İlke Akpinar","is_ca":true},{"name":"Chantal E. Atwood","is_ca":true},{"name":"Lesly Deuchar","is_ca":true},{"name":"Mohit Bhutani","is_ca":false},{"name":"Richard Leigh","is_ca":true},{"name":"Michael K. Stickland","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04406145939402985,"gpt":0.3905816534093894,"spread":0.3465201940153596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001367321,0.0002419012,0.00274816,0.0004684417,0.0001073949,0.00005263151,0.000285962,0.00006347753,0.0005581055],"category_scores_gemma":[0.0002532326,0.0002060972,0.0007764514,0.0004404509,0.0001409796,0.000268323,0.00009149237,0.0001175098,0.000005081142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006412166,"about_ca_system_score_gemma":0.0007228342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008512274,"about_ca_topic_score_gemma":0.0001746832,"domain_scores_codex":[0.9971259,0.0005254087,0.001028089,0.0004960313,0.0005402243,0.0002842955],"domain_scores_gemma":[0.9967045,0.0007439808,0.0006207827,0.0003160497,0.001437902,0.0001768327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9643357,0.000683504,0.005367922,0.000296863,0.01057002,0.000001330799,0.009367884,0.006248087,0.0002698578,0.00002071118,0.00009782156,0.002740273],"study_design_scores_gemma":[0.7506023,0.0003043433,0.005975768,0.00007645976,0.01816871,5.146497e-8,0.003803206,0.2201068,0.0007378115,0.00004006883,0.00002126918,0.0001632632],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9619532,0.0003075826,0.0001585274,0.0001625953,0.0002263968,0.03329537,0.003469863,0.00002248145,0.0004039716],"genre_scores_gemma":[0.9822604,0.00004739337,0.0001506409,0.00003821365,0.00009659211,0.005380861,0.01196267,0.00004447534,0.00001873405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2138587,"threshold_uncertainty_score":0.8404399,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2925255986","doi":"10.1007/s41669-019-0153-0","title":"All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe","year":2019,"lang":"en","type":"letter","venue":"PharmacoEconomics - Open","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Diversity (politics); Plenary session; Political science; Engineering ethics; Library science; Engineering; Computer science; Law","authors":[{"name":"Jacoline C. Bouvy","is_ca":false},{"name":"Michelle Mujoomdar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1358255975837082,"gpt":0.3684017683739486,"spread":0.2325761707902403,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001109116,0.0002570118,0.0005888494,0.00009886,0.0006983821,0.0001695574,0.001537482,0.0003269167,0.006031669],"category_scores_gemma":[0.00003832648,0.0002688613,0.00007150673,0.00006966365,0.0005330959,0.0005234924,0.005293726,0.000633802,0.0002578778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001277883,"about_ca_system_score_gemma":0.0001792993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003901136,"about_ca_topic_score_gemma":0.00004908509,"domain_scores_codex":[0.9981491,0.0002783005,0.000272029,0.0005743758,0.0003159935,0.0004102138],"domain_scores_gemma":[0.9988026,0.0003328501,0.0003093816,0.0002735169,0.00009201434,0.0001896423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005012491,0.00002256469,0.009545402,0.0001682299,0.0002227941,0.0001135741,0.0121402,0.000002690432,0.00004791158,0.00006316577,0.9766651,0.000958255],"study_design_scores_gemma":[0.0008979665,0.00002956353,0.001045977,0.00003895756,0.0003425234,0.000009011274,0.002183615,0.00001545629,0.00006611073,0.0001529634,0.994885,0.0003328638],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.2508372,0.0007589763,0.000005714117,0.4995398,0.003188348,0.002321297,0.001943368,0.00005401023,0.2413514],"genre_scores_gemma":[0.04484236,0.01149625,0.0001056124,0.8263053,0.002677483,0.000011689,0.0004059537,0.00005612863,0.1140992],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3267656,"threshold_uncertainty_score":0.9999763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010862135","doi":"10.1007/s41669-020-00204-z","title":"Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews","year":2020,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Bell (Canada)","funders":"Janssen Pharmaceuticals","keywords":"Medicine; Rituximab; Follicular lymphoma; Cost effectiveness; Obinutuzumab; Systematic review; MEDLINE; Quality-adjusted life year; Bendamustine; Oncology; Internal medicine; Lymphoma","authors":[{"name":"Neerav Monga","is_ca":true},{"name":"Jamie Garside","is_ca":false},{"name":"Joan Quigley","is_ca":false},{"name":"Peter O’Donovan","is_ca":false},{"name":"Christoph Tapprich","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false},{"name":"Catherine Thiéblemont","is_ca":false},{"name":"Christina Loefgren","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3293607670708495,"gpt":0.4732217885049921,"spread":0.1438610214341426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002344471,0.0006306586,0.008493211,0.0002041127,0.00006977221,0.0001304558,0.0002604912,0.000151348,0.00002792349],"category_scores_gemma":[0.0002644143,0.0003976141,0.0002477108,0.0003365432,0.00007442606,0.0002420849,0.0003264604,0.0001680958,0.0000138171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001489432,"about_ca_system_score_gemma":0.0008624193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003043267,"about_ca_topic_score_gemma":0.0001639187,"domain_scores_codex":[0.9941295,0.002072735,0.002519975,0.0008107923,0.0001661959,0.0003007384],"domain_scores_gemma":[0.9955641,0.001098978,0.002271282,0.0004788194,0.00007045951,0.0005163605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002434762,0.001625114,0.06308495,0.5594091,0.00478862,0.00009898005,0.0001429298,0.000002961022,1.070799e-7,0.00006073615,0.0005786854,0.3677731],"study_design_scores_gemma":[0.05937906,0.001456209,0.1008565,0.3065531,0.01030302,0.0001342544,0.00005692618,0.00009744721,0.000003060761,0.00000236611,0.5199296,0.001228349],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02025334,0.9544085,0.000003538441,0.0001106944,0.00004302425,0.02486653,0.0002620716,0.00001169321,0.00004060491],"genre_scores_gemma":[0.004683638,0.991759,0.0001733798,0.0004551565,0.00001851613,0.002282614,0.0005297805,0.00007175573,0.00002612833],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5193509,"threshold_uncertainty_score":0.9998476,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975748077","doi":"10.1007/s41669-019-00180-z","title":"Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Azacitidine; Medicine; Myeloid leukemia; Cost effectiveness; Internal medicine; Oncology; Cytarabine; Population; Hypomethylating agent; Environmental health; DNA methylation","authors":[{"name":"Doug Coyle","is_ca":true},{"name":"Pierre Villeneuve","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02051727135984825,"gpt":0.3295631370827624,"spread":0.3090458657229141,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006567334,0.000188987,0.0004525758,0.0001858994,0.00002385904,0.00004671575,0.0003695638,0.00006410479,0.003735972],"category_scores_gemma":[0.000007175634,0.0001586252,0.00003072241,0.00009890501,0.00006456808,0.0004411583,0.0001458056,0.0002541879,0.001011585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002164055,"about_ca_system_score_gemma":0.001937536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006240565,"about_ca_topic_score_gemma":0.0001433239,"domain_scores_codex":[0.9986708,0.00005919178,0.0003527618,0.0003932633,0.0002380108,0.0002859663],"domain_scores_gemma":[0.999078,0.00005298005,0.0001983284,0.0003670877,0.0001822091,0.0001214455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02369739,0.0007558512,0.8302199,0.0004324993,0.003561429,0.00006419597,0.0008753948,0.02568912,0.007804716,0.001257899,0.02723956,0.07840203],"study_design_scores_gemma":[0.198482,0.006128869,0.5791063,0.0007502914,0.002088072,0.000116638,0.0003579055,0.1212355,0.05453187,0.0005135732,0.03460189,0.002087094],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.971776,0.00001824025,0.000006814093,0.0002253501,0.0001250038,0.00230326,0.0001188916,0.00001148392,0.02541497],"genre_scores_gemma":[0.99759,0.00006717975,0.000478802,0.000285168,0.00005832765,0.00009900809,0.0002529582,0.00005363041,0.001114916],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2511136,"threshold_uncertainty_score":0.9997662,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2609661473","doi":"10.1007/s41669-017-0022-7","title":"Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Toronto Public Health; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Tufts Medical Center","keywords":"Medicine; Oncology; Internal medicine","authors":[{"name":"Kavisha Jayasundara","is_ca":true},{"name":"Murray Krahn","is_ca":true},{"name":"Muhammad Mamdani","is_ca":true},{"name":"Jeffrey S. Hoch","is_ca":true},{"name":"Paul Grootendorst","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6709276885782226,"gpt":0.5865158343262132,"spread":0.08441185425200937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009297839,0.0002920259,0.001543006,0.0002240795,0.000924045,0.0007333686,0.001324467,0.0001827945,0.001200862],"category_scores_gemma":[0.001306141,0.0004022754,0.0001387594,0.00003943841,0.0001597629,0.002011015,0.0004601932,0.0002485577,0.0007295405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001869878,"about_ca_system_score_gemma":0.0003118257,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02324602,"about_ca_topic_score_gemma":0.01396579,"domain_scores_codex":[0.9953625,0.0005295528,0.002753424,0.0008451921,0.00003628946,0.0004731063],"domain_scores_gemma":[0.9920932,0.004104037,0.002756166,0.0007688984,0.00004790939,0.0002297846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004946636,0.001757964,0.7291046,0.0006830196,0.001711178,0.0002574549,0.006053397,0.0004879291,0.0001669516,0.1987511,0.04962122,0.006458524],"study_design_scores_gemma":[0.1351267,0.00168972,0.2984662,0.0005808519,0.0002612272,0.0001906724,0.0115111,0.1362444,0.001550192,0.1551214,0.2545908,0.004666625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663998,0.0003637479,0.0004602569,0.01072473,0.002529069,0.006167796,0.006853427,0.00002783236,0.00647338],"genre_scores_gemma":[0.9902639,0.000125798,0.001021111,0.003887893,0.0003889558,0.003702309,0.0004750291,0.00004608303,0.00008887508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4306384,"threshold_uncertainty_score":0.9998429,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2748882349","doi":"10.1007/s41669-017-0053-0","title":"Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; Confidence interval; Health care; Pharmaceutical care; Pulmonary tuberculosis; Public health; Retrospective cohort study; Tuberculosis; Family medicine; Emergency medicine; Internal medicine; Nursing; Pharmacy","authors":[{"name":"Pimwara Tanvejsilp","is_ca":true},{"name":"Mark Loeb","is_ca":true},{"name":"Jonathan Dushoff","is_ca":true},{"name":"Feng Xie","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1341411480989907,"gpt":0.4376703003657257,"spread":0.303529152266735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005511048,0.0001590524,0.0006251745,0.0000814704,0.0001545649,0.00006546089,0.0002876809,0.00007027605,0.0001068399],"category_scores_gemma":[0.0002137963,0.0001198778,0.00003954149,0.00001873471,0.0001541177,0.0002181667,0.0002410419,0.0001560054,0.00001081631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001837984,"about_ca_system_score_gemma":0.0001741259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005974341,"about_ca_topic_score_gemma":0.003456407,"domain_scores_codex":[0.9987905,0.0001690941,0.0003054849,0.0003378523,0.00005605718,0.0003410118],"domain_scores_gemma":[0.9988048,0.000309476,0.0002237873,0.000383698,0.0000326103,0.0002455955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001913737,0.0002812134,0.9809246,0.00004381293,0.0002649264,0.0001403019,0.0004987085,0.000008338731,0.0006385832,0.00003909908,0.003674525,0.01157212],"study_design_scores_gemma":[0.00959442,0.0013471,0.9299287,0.0002783735,0.0001120313,0.00005894883,0.0005443408,0.00156236,0.004104513,0.0002008666,0.05195535,0.0003130151],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736924,0.0007801624,3.887302e-7,0.01705713,0.00005027774,0.0009031461,0.00008919879,0.000009616225,0.007417643],"genre_scores_gemma":[0.9952199,0.001688561,0.00008033055,0.001925785,0.00006412006,0.00009977818,0.00007117893,0.00002293009,0.0008274595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05099596,"threshold_uncertainty_score":0.9031457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4364376102","doi":"10.1007/s41669-023-00409-y","title":"Economic Evaluation Comparing Virtual Reality with Child Life Programming for Non-sedated Pediatric Medical Imaging: A Cost-Consequence Analysis","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Western University; BC Children's Hospital; University of British Columbia","funders":"Mitacs","keywords":"Virtual reality; Psychology; Computer science; Human–computer interaction","authors":[{"name":"John Jacob","is_ca":true},{"name":"Chelsea Stunden","is_ca":true},{"name":"Dhayanand Deenadayalan","is_ca":true},{"name":"Luke Thomas","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06749193653518161,"gpt":0.4162319603709268,"spread":0.3487400238357452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005702155,0.0003047051,0.0008242902,0.0008222335,0.0002182729,0.000246753,0.0008365461,0.00008347872,0.0002794022],"category_scores_gemma":[0.0002926137,0.0003127931,0.0001865268,0.0008357051,0.0001010879,0.0005493214,0.0004868118,0.000299906,0.0001011513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006228565,"about_ca_system_score_gemma":0.001014363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007486856,"about_ca_topic_score_gemma":0.0002315615,"domain_scores_codex":[0.997306,0.0001445909,0.0007974462,0.0008503078,0.0003306255,0.0005709794],"domain_scores_gemma":[0.9980739,0.0003017855,0.0004548632,0.0005353318,0.0001409416,0.0004931801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001638604,0.000337958,0.8997427,0.0002654941,0.003155795,0.0001199249,0.0002679961,0.01102658,0.00003107232,0.000279035,0.04940056,0.03373431],"study_design_scores_gemma":[0.006348332,0.0001015545,0.04602111,0.0000297016,0.004842091,0.00002265529,0.0001273414,0.9364297,0.00009205715,0.0001178968,0.005421351,0.0004462471],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9537786,0.00008278779,0.02027587,0.009285989,0.0002953048,0.01121399,0.0001140866,0.0007472955,0.004206045],"genre_scores_gemma":[0.9920252,0.0004643696,0.001465237,0.001674744,0.0006180492,0.002385371,0.001237662,0.00006013246,0.0000692094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9254031,"threshold_uncertainty_score":0.9999324,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4286494041","doi":"10.1007/s41669-022-00355-1","title":"Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX)","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Oxford University Hospitals NHS Foundation Trust; Dalhousie University; University of Oxford; Health Technology Assessment Programme; Imperial College London; University of Bristol; National Institute for Health and Care Research; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Obstetrics; Confidence interval; Gestation; Pregnancy; Pediatrics","authors":[{"name":"Rachael Hunter","is_ca":false},{"name":"Alice Beardmore‐Gray","is_ca":false},{"name":"Melanie Greenland","is_ca":false},{"name":"Louise Linsell","is_ca":false},{"name":"Edmund Juszczak","is_ca":false},{"name":"Pollyanna Hardy","is_ca":false},{"name":"Anna Placzek","is_ca":false},{"name":"Andrew Shennan","is_ca":false},{"name":"Neil Marlow","is_ca":false},{"name":"Lucy C. Chappell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.077040696318964,"gpt":0.366985040062162,"spread":0.289944343743198,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006397733,0.0002327804,0.0008454393,0.0002490606,0.0003068523,0.00004642664,0.0006610904,0.00003595673,0.001582556],"category_scores_gemma":[0.00001336992,0.0002215233,0.000329,0.0002998752,0.00006121139,0.00022079,0.001136279,0.000181841,0.000005374374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001958224,"about_ca_system_score_gemma":0.00009142317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001707726,"about_ca_topic_score_gemma":0.00008908405,"domain_scores_codex":[0.998219,0.0001042637,0.0006284914,0.0005474782,0.000142545,0.0003581849],"domain_scores_gemma":[0.99879,0.0002029037,0.0003129517,0.0005229984,0.00004893064,0.0001222351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.206951,0.003911328,0.4729756,0.002787455,0.1152466,0.0003958384,0.04216715,0.01369205,0.003416871,0.001971415,0.04332091,0.09316383],"study_design_scores_gemma":[0.04151934,0.003726942,0.5425206,0.0002740365,0.03419297,0.00003691193,0.004493991,0.1594968,0.0178944,0.001332043,0.1924592,0.00205273],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834518,0.0006459539,0.0002646082,0.0004296609,0.0002985939,0.004780356,0.001343276,0.00004572029,0.008740057],"genre_scores_gemma":[0.9928098,0.0005009396,0.001204963,0.0009242285,0.00003445151,0.002151055,0.0002520826,0.0000304032,0.002092024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1654316,"threshold_uncertainty_score":0.9993301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396576727","doi":"10.1007/s41669-024-00484-9","title":"Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs","year":2024,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"European Organisation for Research and Treatment of Cancer","keywords":"Lung cancer; Quality of life (healthcare); EQ-5D; Medicine; Construct validity; Cancer; Physical therapy; Disease; Psychometrics; Clinical psychology; Health related quality of life; Oncology; Nursing; Internal medicine","authors":[{"name":"Micha J. Pilz","is_ca":false},{"name":"Simone Seyringer","is_ca":false},{"name":"Imad Al-Naesan","is_ca":false},{"name":"Madeleine King","is_ca":false},{"name":"Andrew Bottomley","is_ca":false},{"name":"Richard Norman","is_ca":false},{"name":"Lisa Schlosser","is_ca":false},{"name":"Tobias Hell","is_ca":false},{"name":"Eva‐Maria Gamper","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7914805543456943,"gpt":0.5302336988651476,"spread":0.2612468554805467,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.05033107,0.0003774335,0.002047411,0.0003046005,0.0002205338,0.0002595824,0.001830559,0.000142263,0.001541841],"category_scores_gemma":[0.001672006,0.0003784542,0.0001812637,0.000287248,0.0001153006,0.001346622,0.0006338096,0.0003899987,0.00005153391],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00558434,"about_ca_system_score_gemma":0.003112896,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07663497,"about_ca_topic_score_gemma":0.0148898,"domain_scores_codex":[0.9890141,0.00135403,0.007463529,0.001181407,0.0004234966,0.000563426],"domain_scores_gemma":[0.993307,0.0007017427,0.004397448,0.001115394,0.0003304179,0.0001480318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.000939996,0.001261546,0.679796,0.0112975,0.003565492,9.131571e-7,0.03311793,0.03805009,0.0003201243,0.007208438,0.2039504,0.02049161],"study_design_scores_gemma":[0.006711046,0.00003167455,0.02565314,0.003218227,0.0002465981,3.785659e-7,0.002952355,0.8797244,0.0002865531,0.001059504,0.07941607,0.000700078],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7935886,0.1620846,0.0001189641,0.01077661,0.005809037,0.01232846,0.01470241,0.00003575857,0.0005555238],"genre_scores_gemma":[0.9893355,0.005746566,0.0001459474,0.002297398,0.0004039396,0.001670529,0.000257829,0.00007616871,0.00006610531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8416743,"threshold_uncertainty_score":0.9998667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2965330563","doi":"10.1007/s41669-019-0159-7","title":"Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Salmonella and Campylobacter epidemiology","field":"Agricultural and Biological Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Typhoid fever; Widal test; Test (biology); Economic evaluation; Medicine; Decision tree; Computer science; Salmonella typhi; Artificial intelligence","authors":[{"name":"Samuel N. Frempong","is_ca":false},{"name":"Andrew Sutton","is_ca":true},{"name":"Clare Davenport","is_ca":false},{"name":"Pelham Barton","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05873437870558364,"gpt":0.3704102202133898,"spread":0.3116758415078062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00159768,0.000169047,0.0004018524,0.000028982,0.00006233958,0.0001253433,0.0009548222,0.00006850374,0.001458293],"category_scores_gemma":[0.0002284381,0.00008138613,0.00006680028,0.00014397,0.00002252659,0.0003049012,0.0004525074,0.0001347264,0.001048396],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000189989,"about_ca_system_score_gemma":0.00005606869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005119962,"about_ca_topic_score_gemma":0.001807657,"domain_scores_codex":[0.9985592,0.0001689976,0.0004704078,0.0004272067,0.00006185254,0.000312332],"domain_scores_gemma":[0.9978179,0.001614204,0.0002219779,0.0001330222,0.00004525308,0.0001676033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002532719,0.0001291381,0.6599322,0.000007152167,0.00004132502,9.975355e-7,0.0006384965,0.0001845095,0.1719093,0.00007304925,0.006281521,0.160549],"study_design_scores_gemma":[0.0005421124,0.0003051689,0.9791017,0.00001625349,0.0000267158,0.000002357098,0.0001979997,0.0007887919,0.004829701,0.0001777392,0.0138066,0.0002048338],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878004,0.00002275215,0.000001404321,0.006116522,0.0004412963,0.003779248,0.0002373347,0.000009363253,0.001591716],"genre_scores_gemma":[0.9944437,0.00002179847,0.00002449082,0.004628626,0.0002420791,0.0002717834,0.0000697739,0.000003132885,0.0002946736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3191696,"threshold_uncertainty_score":0.9997294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2943673305","doi":"10.1007/s41669-019-0139-y","title":"A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers","year":2019,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact; Programs for Assessment of Technology in Health Research Institute","funders":"Mitacs","keywords":"Agency (philosophy); Population; Health care; Business; Family medicine; Medicine; Public health; Cost–benefit analysis; Private sector; Actuarial science; Accounting; Environmental health; Political science; Nursing","authors":[{"name":"Naghmeh Foroutan","is_ca":true},{"name":"Jean‐Éric Tarride","is_ca":true},{"name":"Feng Xie","is_ca":true},{"name":"Fergal Mills","is_ca":false},{"name":"Mitchell Levine","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6885709978218029,"gpt":0.6102526625261878,"spread":0.07831833529561505,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.02464997,0.0008391678,0.009238577,0.001593724,0.0005555193,0.0005355155,0.002668281,0.0003528004,0.005211156],"category_scores_gemma":[0.00153832,0.0007436908,0.0009779441,0.001290891,0.0003489634,0.001060845,0.0006085619,0.001000986,0.001024305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002443797,"about_ca_system_score_gemma":0.001684934,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.09076011,"about_ca_topic_score_gemma":0.03636184,"domain_scores_codex":[0.986047,0.001429556,0.01001687,0.001394776,0.0001461976,0.0009656356],"domain_scores_gemma":[0.9846858,0.002516988,0.01015559,0.001436217,0.0001717055,0.001033676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004045736,0.0004764796,0.04516364,0.08296628,0.02798264,0.000003592877,0.001660142,0.0001240336,1.835917e-7,0.02599566,0.615389,0.2001979],"study_design_scores_gemma":[0.0007834914,0.00006229652,0.0004554339,0.003638052,0.003263822,0.00000667069,0.0001070185,0.003878936,1.370013e-7,0.0001912022,0.9869004,0.0007125601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001528532,0.9213009,0.00006510639,0.06433647,0.0007896245,0.006404794,0.003613513,0.00002731048,0.003309386],"genre_scores_gemma":[0.001448955,0.982523,0.0003177663,0.01241686,0.0002444224,0.0006694651,0.002033114,0.0001136546,0.0002327717],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3715114,"threshold_uncertainty_score":0.9997535,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2962517794","doi":"10.1007/s41669-019-0161-0","title":"The Costs of Industry-Sponsored Drug Trials in Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Innovative Medicines Canada","keywords":"Cancer drugs; Medicine; Clinical trial; Drug; Business; Pharmacology; Internal medicine","authors":[{"name":"Dat T. Tran","is_ca":true},{"name":"İlke Akpinar","is_ca":true},{"name":"Philip Jacobs","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4439171069277689,"gpt":0.573564349915947,"spread":0.1296472429881781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01101381,0.0003189413,0.001066558,0.0000905127,0.0002540902,0.00007879686,0.001891547,0.0004440875,0.00670497],"category_scores_gemma":[0.0004642352,0.0002658847,0.0001348479,0.0002603037,0.0001452586,0.0003355204,0.0005462311,0.003516982,0.0002161625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001317355,"about_ca_system_score_gemma":0.003706628,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4567232,"about_ca_topic_score_gemma":0.4831818,"domain_scores_codex":[0.9933887,0.003337791,0.001780876,0.0004790847,0.0001578793,0.0008556595],"domain_scores_gemma":[0.9921156,0.006089936,0.0007254764,0.0004133019,0.00010066,0.0005550468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0118496,0.0006963131,0.5651241,0.000271415,0.001286944,0.0001125197,0.001039889,0.0109274,0.01632272,0.02574297,0.2406172,0.1260089],"study_design_scores_gemma":[0.009190374,0.00005754787,0.007377818,0.00006204447,0.000164108,0.00001576048,0.001728813,0.01210195,0.08049966,0.0008185534,0.8873693,0.0006141205],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9576337,0.0008137799,5.120239e-7,0.01483295,0.003194072,0.002582405,0.0004433602,0.00001564976,0.02048358],"genre_scores_gemma":[0.9855712,0.0009691434,0.00001911535,0.01035673,0.0001998286,0.0001692322,0.00002831474,0.00003449147,0.00265197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6467521,"threshold_uncertainty_score":0.9999793,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}